US20070282199A1 - Methods of injecting fluids for use in imaging and therapeutic procedures where feedback enables adjustment of injection parameters - Google Patents
Methods of injecting fluids for use in imaging and therapeutic procedures where feedback enables adjustment of injection parameters Download PDFInfo
- Publication number
- US20070282199A1 US20070282199A1 US11/752,478 US75247807A US2007282199A1 US 20070282199 A1 US20070282199 A1 US 20070282199A1 US 75247807 A US75247807 A US 75247807A US 2007282199 A1 US2007282199 A1 US 2007282199A1
- Authority
- US
- United States
- Prior art keywords
- patient
- injection
- injection parameters
- contrast medium
- delivery system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/80—General characteristics of the apparatus voice-operated command
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/20—ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/12—Pressure infusion
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/13—Infusion monitoring
Definitions
- This invention relates generally to the field of medical devices for delivering contrast media during medical diagnostic and therapeutic imaging procedures and more particularly, this invention relates to improved contrast media delivery systems and methods of use which allow adjustment of contrast media concentration and injection parameters either before or during an injection procedure to provide patient specific dosing of contrast media, thus decreasing the waste and cost of these procedures while increasing their efficiency.
- the appropriate dose for many medications is related to the size and weight of the patient being treated. This is readily apparent in the difference between the recommended doses which most medications have for adults and children.
- the appropriate dose of contrast media for a given medical imaging procedure is equally dependent upon the size and weight of the patient being examined as well as other additional factors.
- Standard protocols are used primarily to minimize the potential for errors by hospital personnel and decrease the likelihood of having to repeat the procedure, an occurrence which requires that the patient be exposed to additional radiation and contrast media.
- Prior art contrast delivery systems once a bottle of contrast media was opened for use on a patient it could not be used on another patient due to contamination considerations.
- Existing contrast delivery systems do not prevent the source of contrast media used for an injection from being contaminated with body fluids of the patient.
- the containers which supplied the contrast media were generally therefore all single use containers and, consequently, the entire container of contrast media was given to the patient being studied.
- Present protocols include delivery rate in volume per unit time. Usually the injection is at a constant flow rate or with one change between two fixed flow rates. However, physically, pressure drives fluid flow. Thus, present fluid delivery systems employ some type of servo to develop the pressure needed to deliver the programmed flow rate, up to some pressure limit. The pressure needed depends upon the viscosity of the fluid, the resistance of the fluid path, and the flow rate desired. This is considerably better than the older injector systems which controlled pressure at a set value, and let the flow rate vary.
- the system incorporates a source of contrast media and, if desired, a diluent. Each is sufficiently isolated from the patient to prevent contamination.
- the contrast media preferably has a concentration which is the highest that would be used in an injection procedure so that the operator may combine the contrast media with a diluent and select virtually any concentration of contrast media desired for any given procedure.
- the concentration of the contrast media injected into a patient may be varied during the injection procedure by varying the ratio of diluent to contrast media. Each patient therefore receives only the amount of contrast media necessary to provide a proper diagnostic image.
- this system will be much more versatile and useful if the operator is able to select and adjust contrast media concentration and other injection parameters based on patient information or feedback received during the injection imaging procedures. Additionally, this system would be more efficient if it were capable of automatically choosing the appropriate concentration and injection rate for a given patient. Even more utility and efficiency would be realized from a system that is capable of automatically adjusting concentration and other injection parameters during an injection procedure based on feedback related to the resultant image quality.
- the invention includes apparatus and methods for medical contrast imaging and comprises embodiments which provide patient specific dosing of contrast media in a variety of medical imaging procedures, as opposed to fixed protocols.
- the protocol variables are determined by the system and are dependent upon patient specific information supplied by the operator, and/or information measured by the contrast delivery system either prior to, or during the injection procedure.
- information specific to any given patient is entered into the system and the appropriate concentration and injection parameters are computed before initiating the imaging fluid injection procedure.
- the system is then ready for injection of a patient. It is important to note that the system is not limited to choosing a particular concentration of contrast media or injection rate for the entire procedure, or even a moderate number of phases with constant velocity as present injectors can now do, but rather is capable of selecting an injection profile which may include a continuously varying injection rate and/or concentration of contrast media.
- the particular injection profile selected by the system is designed to provide the best image quality for the particular patient based on a variety of factors such as patient weight and circulation system variables.
- feedback from at least one sensor is employed by the control system to modify the concentration of the contrast media, injection rate, and/or total volume during the injection procedure.
- Various types of sensors are disclosed for use with this system, in particular, various electromagnetic sensors or video monitoring devices provide feedback for the system or operator to use.
- angiography where the contrast is injected into the region of interest, the sensor needs to make a measurement in that region of interest.
- CT and MR it is sufficient for the sensor to measure a remote area of the body, although measuring within the region of interest (ROI) could be advantageous in some applications.
- the sensor provides an indication of the actual amount of contrast media in the patient. This is used to calculate the appropriate injection rate or concentration of contrast media to provide a diagnostic image with minimum risk and cost.
- the concentration, or other injection parameters may be manually adjusted based on images seen by the doctor or operator.
- a final version of the invention is disclosed which works to further improve doctors confidence by providing tactile feedback to a doctor or operator in addition to visual or other sensed feedback on the amount of contrast media in a patient. This provides the operator with additional information to use in determining injection rate, concentration and pressure for the injection procedure.
- FIG. 1 is a flow diagram illustrating the prior art procedure for implementing a standard protocol.
- FIG. 2 is a flow diagram for a system of the present invention in which injection parameters are calculated based on patient specific information.
- FIG. 3 a illustrates an embodiment of the present invention which employs the improved procedure for calculating injection parameters of the present invention.
- FIG. 3 b illustrates an embodiment of the present invention which employs the improved procedure for calculating the filling of a syringe used with an injector.
- FIG. 4 is a flow diagram outlining an injection procedure which incorporates a sensor for sensing contrast concentration in a patient during a test injection.
- FIG. 5 is a flow diagram outlining an injection procedure which incorporates a sensor for sensing contrast concentration in a patient for modifying the injection parameters throughout the injection.
- FIG. 6 illustrates an example of a sensor for use with the present invention.
- FIG. 7 illustrates the present invention wherein the system is able to automatically adjust fluid flow rate based on the resulting image.
- FIG. 8 illustrates an embodiment of a tactile feedback pressure measurement device which allows the system operator to adjust injection parameters based on tactile feedback.
- FIG. 9 illustrates an embodiment of the present invention which incorporates a Tactile Feedback Control (TFC) unit which allows the system operator to adjust injection parameters based on this sensor as well as the resulting image.
- TFC Tactile Feedback Control
- the TFC is in fluid communication with the fluid being injected.
- FIG. 10 a illustrates an embodiment of the present invention which incorporates a Tactile Feedback Control (TFC) unit which allows the system operator to adjust injection parameters based on this sensor as well as the resulting image.
- TFC Tactile Feedback Control
- FIG. 10 b illustrates an embodiment of the TFC in greater detail.
- FIGS. 11 a - d illustrate various relationships between TFC inputs and contrast delivery system actions which an operator could select with the system.
- FIG. 12 illustrates disposable manifolds operated by electronic solenoids or motors which are designed for use with the present invention during cardiology.
- FIG. 13 illustrates a manifold for use with the present invention during cardiology procedures.
- FIG. 14 illustrates a system by which the manifold illustrated in FIG. 13 is voice-activated.
- FIG. 1 is a flow diagram showing a conventional medical imaging procedure for implementation of a standard protocol. This diagram is indicated generally by the numeral 10 .
- the imaging procedure standard protocol is selected at first operative step 11 , and a decision is made at step 12 as to whether the patient's weight is within a broad range considered to be appropriate for the particular concentration of contrast media and set of injection parameters for the selected protocol. If the patient's weight is within the broad range of weights acceptable for the particular contrast media and set of injection parameters, the standard protocol is determined to be appropriate at step 14 . The patient is injected and the image is acquired at step 18 . Alternatively, if the weight of the patient is not within the given range, an alternate contrast media concentration and set of injection parameters are chosen at step 16 .
- the patient is then injected and the image is acquired at step 18 .
- the operator then reviews the image at step 20 . If the image is satisfactory, the procedure is successfully completed and the system is prepared for the next imaging procedure with this patient or another patient at step 22 .
- step 24 If the image is not satisfactory, the procedure must be repeated as noted at step 24 . A decision is then made as to whether there is a specific problem with the system or selected protocol at step 26 . If there is a problem with the protocol, the selected protocol is revised at step 28 . Alternatively, if the initially selected protocol is appropriate, step 14 is repeated and the patient is injected at step 18 . As noted, this type of system and its lack of versatility has significant disadvantages compared with the system of the present invention.
- the present invention takes advantage of the increased versatility of the advances set forth in the co-pending application previously noted and further advances the art by adding automatic functions and increased versatility.
- a flow-diagram illustrating an improved contrast media delivery of the present invention is shown generally by the numeral 30 in FIG. 2 .
- the operator initially inputs information relating to the patient such as size and weight in addition to other factors related to the particular imaging procedure being performed at first operative step 32 .
- This information could be stored in a hospital computer and simply downloaded to the imaging system.
- the Electronic Control System (ECS) of the contrast media delivery system determines the appropriate concentration of the contrast media and other injection parameters such as flow rates, volume, time delay, etc. at step 34 .
- the computed concentration of contrast media and injection parameters are then displayed at step 36 .
- the step of displaying parameters for user review is optional. As this capability is first introduced, operators will want to retain control. As they become familiar with the equipment and gain confidence with it, it will be possible to manufacture and market systems which no longer display injection parameters for operator review. In the preferred embodiment, however, the system operator then reviews the calculated parameters at step 38 and decides whether to manually modify the parameters at step 40 or proceed with the injection of the patient at step 42 .
- the injection begins in step 42 , the image is acquired, and the system operator or physician reviews the resulting image at step 44 . If the image is satisfactory for diagnosis, the image is stored and the procedure is complete. The system may be prepared for the next imaging procedure at step 46 .
- the operator may choose to perform optional step 47 in which the operator may input information to modify the algorithm which determines the injection parameters so that before the system stores the parameters they are set to levels which would have provided an image which is mote personally satisfactory.
- the system software keeps track of the various injection parameters a doctor or operator selects for patients of a particular size and for a given procedure. These factors are analyzed for preferred tendencies of the doctor or operator so that the system is able to select injection parameters based on the operators personal preferences. By performing this optional step, the system will be able to automatically select operating parameters which provide a more satisfactory image for an individual. If the operator chooses to perform optional step 47 , the system is prepared for the next imaging procedure upon completion of this step.
- the image parameters are extracted at step 48 and the ECS is updated at step 49 .
- the ECS then recalculates new parameters and repeats step 34 . The remainder of the procedure is also repeated. It is anticipated that this will happen very seldom once the algorithm is adapted to the doctor's preference.
- FIG. 3 a illustrates an embodiment of the improved contrast media delivery system of the present invention generally at 50 .
- the user interface of the ECS is indicated at 52 with direct connection to the ECS 54 .
- the electronic interface 56 may be connected to other systems which are not shown, such as imaging equipment and the hospital information system. If this interface is connected to the hospital information system, it could rely on this system to receive patient specific information necessary for performing the procedure such as size, weight, etc. An operator would therefore only be required to input a patient number and the appropriate information would be downloaded from the hospital information system.
- the electronic interface 56 is also connected to the imaging equipment 57 .
- the ECS is capable of sending and receiving information so that, for example, the operator only needs to program the CT scanner with the number of slices and section of the body being imaged. This would be transmitted to the contrast delivery system to be used in determining flow rates and delays, etc. Additionally, information relating to image quality or sensed concentration of contrast media is received to allow for automatic adjustment of the system.
- An information scanner 58 is also shown with direct connection to the ECS 54 .
- the information scanner 58 scans information encoded and attached to fluid storage tanks for the contrast container 60 and diluent container 62 .
- the information encoded and read by the scanner 58 includes information such as tank volume, type and concentration of fluid etc. This information is then employed by the ECS in controlling and calculating the implementation of the imaging procedure. Alternatively, this information is downloaded from memory located on a fluid delivery module as noted in the application titled Closed Loop Information Path for Medical Fluid Delivery Systems, Application Serial Number 08/273,665, filed Jul. 12, 1994, now abandoned.
- Contrast and diluent tank volume, type and concentration of fluid is stored in the system memory and is updated after using the system.
- the system is therefore able to automatically warn the operator when the system is running low on contrast or diluent. Additionally, the system is able to warn the operator if the wrong contrast media was connected for a particular procedure.
- the ECS 54 is also connected to respective contrast and diluent heaters 64 , 65 .
- the ECS 54 controls the heaters 64 , 65 through this connection and receives feedback so that the system may make appropriate adjustment of the heaters to provide the desired temperature of contrast media.
- Metering pumps 68 , 69 are connected to the ECS 54 which also controls fluid flow of contrast and diluent through the pumps.
- each of the metering pumps 68 , 69 is connected to the helical vane static mixer 71 which ensures that the desired concentration of contrast media is produced by the system.
- a backflow valve 73 in the fluid flow path to the patient prevents the contrast media from returning to the sources of contrast and diluent 60 , 62 and causing contamination.
- a fluid assurance sensor 75 is also directly connected to the ECS 54 .
- the final element in the fluid path which is connected to the ECS 54 is the pressurizing pump 76 .
- the pressurizing pump 76 provides the desired injection rate of contrast media for the particular procedure.
- a per patient connector 77 is followed by a sterile filter 78 which is also connected in line to prevent contamination of the sources of contrast media and diluent by preventing body fluids of the patient from flowing back into the sources of contrast and diluent.
- the fluid path then flows through connector tube 80 and a medical stopcock 82 .
- a hand held syringe 84 is also connected to a port of the stopcock 82 to allow the doctor to perform what are considered test or scout injections. For example, the doctor may get a small amount of fluid at a concentration, and then do hand powered injections during his manipulations to get a catheter into the proper vessel.
- a contrast media sensor (not shown) is added to the system to provide additional feedback during an injection procedure in order to provide for better monitoring of concentration as it is adjusted by the system.
- FIG. 3 b illustrates a second embodiment of the improved contrast media delivery system of the present invention generally at 50 .
- Most of the system components and their function are identical to those of FIG. 3 a , but instead of the per patient connector 77 , sterile filter 78 , tubing 80 , connector 82 and hand syringe 84 , 3 b has a syringe 79 which is filled with fluid.
- This syringe is then placed in an injector for delivery of the fluid to the patient. Prevention of contamination is accomplished by having the syringe allowed to be filled only once.
- the label printer prints the patient specific injection information, and this label is then read by the ECS of the injector.
- the injector ECS 35 can utilize any of the improved patient specific processes of this invention, such as sensors or tactile feedback controllers, neither of which are shown.
- injector ECS 35 could communicate with the filling station ECS 54 so that the injector is programmed by the filling station.
- a third alternative involves having the filling station user interface 52 display the injector parameters and then the operator enters these parameters into injector ECS 35 via the injector user interface.
- One embodiment, not shown, that uses even less hardware and sophistication consists of only a user interface and an electronic control system.
- the operator enters the patient specific data, and the volume, concentration and injection parameters are displayed for the operator.
- the operator manually fills the syringe using a manual method, such as that supplied by NAMIC, of Glens Falls, N.Y., preserving any unused contrast for the next patient.
- the injector is then automatically or manually programmed according to the patient specific parameters computed, and is ready to inject.
- ECS 54 various devices could be employed to function as the ECS 54 .
- ECS 54 at the very least must incorporate a microprocessor and memory along with control outputs for the various devices. It is understood that software controls the system. The software relies on a variety of factors for calculating the appropriate contrast media concentration and injection parameters for a particular patient.
- the following table provides an outline of the factors which the system may consider in evaluating the appropriate concentration of contrast media and injection rate for a particular patient as well as the general effect an increase in these factors would have on calculation of the injection parameters.
- Some factors such as weight have a continuous effect. A slightly heavier patient gets a little more contrast. Others, such as hydration or kidney function have no effect until some threshold is crossed.
- fuzzy logic or neural networks may be appropriate for implementation of the program, however, a conventional computer program also provides satisfactory results.
- FIG. 4 illustrates a flow-chart of the injection procedure of the present invention with sensor measurement.
- a test injection is made and a contrast media sensor is used to provide feedback on the actual concentration of contrast media within the patient.
- the operator enters the type of imaging procedure to be performed and patient information at first operative step 90 . It is important to note the system will already be aware of the type and concentration of the fluid available in the system tanks because the information scanner would have input this information when the tanks were installed.
- the ECS computes the appropriate concentration of contrast media and the injection parameters such as flow rates, volume, and time delay etc.
- the resultant concentration and injection parameters are then displayed at step 94 .
- the operator then reviews the parameters and decides whether to manually modify the procedure at step 96 .
- a test injection of the patient is performed in step 98 .
- the operator may modify the procedure in step 100 and then perform a test injection of the patient at step 98 .
- a sensor measurement of the concentration of contrast media within the patient's body is then performed at step 102 and a decision is made at step 104 as to whether the results of the sample injection are sufficiently close to the desired value. If the results of the test injection are not satisfactory, the system returns to step 100 to modify the injection parameters, either manually or automatically and then repeats the test injection at step 98 .
- the final injection parameters are selected at step 106 which may involve having the operator fine tune the procedure by making minor adjustments and updating specific parameters to provide more desirable results. If more significant changes are needed, the test injection should be repeated as noted.
- the imaging injection procedure begins at step 108 .
- the operator reviews the image at step 110 and determines whether the procedure produced a satisfactory diagnostic image. If the image is satisfactory, the procedure is complete and the system may be prepared for the next imaging procedure at step 112 .
- Step 113 is an optional step which may be performed before preparing the system for the next imaging procedure if the operator wishes to update the algorithm which determines the injection parameters that are used to customize injection procedure to a doctor's preference.
- the image parameters are extracted at step 114 and the ECS injection parameters are updated at step 115 .
- the procedure is repeated beginning with recalculation of the injection parameters step 92 . It is anticipated that this will happen very seldom once the algorithm has been adapted to the imaging equipment and the doctor's preferences as previously noted.
- FIG. 5 illustrates an alternate procedure for performing an imaging procedure with the improved contrast delivery system of the present invention.
- a sensor measurement is used throughout the injection procedure to provide an indication of the actual concentration of contrast media within the patient.
- information relating to the particular imaging procedure to be performed and patient are input to the system at step first operative step 116 .
- the ECS computes concentration, and other injection parameters such as flow rates, volume, time delay, etc. at step 117 .
- the calculated concentration of contrast media and other injection parameters are then displayed at step 119 and the operator reviews the calculated results and determines whether they are satisfactory at step 120 . If the results appear to be within the desired range, injection of the contrast media begins in step 122 .
- the operator may modify the injection parameters at step 123 before initiating the injection at step 122 .
- a sensor measurement is made at step 125 and a decision is made as to whether the results are satisfactory at step 126 . If they are not satisfactory, the injection parameters are modified at step 127 and the sensor measurement is continued at step 125 .
- the sensor measurement is made and the injection parameters are adjusted throughout the injection process based on the sensor measurements. The adjustments continue until the procedure is complete as indicated at step 128 . If the sensor measurement indicates a serious problem, the system may automatically stop the injection procedure depending on the severity of the problem. Upon completion, the operator then reviews the image at step 130 and decides whether the results are satisfactory.
- Step 132 is an optional step which may be performed before preparing the system for the next imaging procedure if the operator wishes to update the algorithm which determines the injection parameters to customize the injection procedure to a doctor's preference.
- the image parameters are extracted at step 134 and the ECS injection parameters are updated at step 136 .
- the ECS then recalculates the concentration of contrast media and injection parameters at step 117 and the operator repeats remaining steps in the procedure. Again, this will be a seldom occurrence once the doctor's preferences have been included. In this embodiment and all others, the repeat procedure may need to be postponed if the patient is near the maximum daily contrast dose.
- a measure of contrast in the body during an injection and having the ECS be able to continuously adjust fluid concentration, flow rate, and/or timing of the signals to start the imaging equipment provides an ability to optimally adapt the dosing to patient specific parameters which may be unknown or inaccurately estimated before the start of the injection. For example, in a CT injection, contrast may arrive at a site more quickly in some patients than others.
- FIG. 6 illustrates an example of a sensor which can be used with the improved contrast media injection system of the present invention.
- the sensor is shown generally at 140 . It is contemplated that a variety of sensors may be used for evaluating the concentration of contrast media within a patient at particular time. These sensors use various wavelengths of electromagnetic radiation to determine the presence of contrast media.
- the particular sensor disclosed in FIG. 6 is designed for sensing contrast media used during procedures which use x-rays to create the desired image. Therefore this sensor employs a source of x-rays and a receiver for determining the amount of x-ray radiation which passes through the tissue of a patient. It is understood that use of other sensors for x-ray or different types of contrast media could be used in a similar manner.
- the sensor includes a silicon diode radiation detector 142 and source of radioactive material 144 .
- a moveable shield 146 is capable of alternately shielding and exposing the radioactive material 144 to the radiation detector 142 .
- Electronic actuator 148 moves the shield 146 upon command from the ECS.
- the sensor includes control and power cables 150 connected to the ECS not shown. It has been found that a small radioactive source works best.
- a commercially available product which can be used to generate an output which varies depending upon the level of x-rays passing through body tissue is the Lixi scope manufactured by Lixi, Inc. of Downers Grove, Ill. 60515. This product uses a similar design for portable imaging of small body parts such as the hand or ankle.
- this product is designed for producing images, it is also capable of being adapted to provide signals which are proportional to the level of contrast media in a patient.
- the source and detector are placed on opposite sides of a thin tissue region such as the ear lobe, finger tip, or fleshy part of the hand between the thumb and index finger. It is known that the attenuation of the tissue will change as the concentration of x-ray contrast builds up in the blood and then surrounding tissue. It should be noted that the radioactive source should be shielded when not in use.
- IR infrared
- iodinated contrast interferes with the signals used to make oxygen measurements with pulse oximeters and that these systems are capable of measuring the level of iodinated contrast.
- Most x-ray contrasts contain a benzene ring with three iodine atoms attached at positions 1 , 3 and 5 .
- Various organic molecules are attached at positions 2 , 4 and 6 .
- the infrared spectrum for iodine atoms bonded to a benzene ring is unlike those for naturally occurring compounds. Dual or multiple wavelengths help to minimize interference or prevent positioning differences from giving incorrect readings. Sensors with other visible, IR or different electromagnetic wavelengths would be used for MRI or ultrasound contrast materials.
- Another sensor which could be used with the improved injection system of the present invention is a pressure sensor inserted into a vessel.
- a tiny pressure sensor on an IC such as those made by SenSim, Inc., Sunnyvale, Calif., are capable of providing this type of feedback.
- a dual lumen catheter and a conventional blood pressure monitor could be also used.
- the flow rate of the injector would be adjusted based upon the sensed intra-luminal pressure.
- the pressure within the vein could be used to limit or appropriately adjust flow rate or concentration to prevent vessel damage or extravasation.
- appropriate adjustment would minimize backflow by timing variations in flow rate to match internal variations due to pressure waves created by the heart.
- the sensor will send a feedback signal to the ECS such as a voltage proportional to the concentration of contrast media present in a patient.
- the system could then either provide this information to the system operator for manual adjustment of the injection parameters, or alternatively, the system could use these signals to automatically adjust the concentration of the contrast media or the flow rate to provide a more desirable image.
- the delay between change in injection parameter and effect is small enough so that the operator may be part of the feedback loop.
- the delay is longer and variable, so having the ECS measure and automatically account for the delay is preferable.
- FIG. 7 illustrates another embodiment of the present invention.
- the system is capable of automatically adjusting the injection parameters to alter the image produced by the system based upon feedback from the actual image.
- This embodiment includes an image processor 160 which analyzes a bitmap of the video image produced by the contrast delivery system in conjunction with the imaging equipment 57 .
- the operator 162 selects one area of interest on the image via the monitor 163 , for example, by moving a box or pointer over the area via a user interface such as a mouse and then selecting the position by clicking the mouse.
- the user selects a desired area of interest such as a blood vessel being examined.
- the image processor 160 then calculates the average intensity of the pixels in the designated area.
- pixel intensity would be proportional to the amount of contrast media in the patient's body due to the effect on the electromagnetic wave or ultrasonic energy wave being used for the imaging procedure. Depending upon the resultant average pixel intensity, the system then makes appropriate adjustments in contrast concentration and injection rate.
- a video image for providing feedback to make adjustments to the injection parameters requires real time or approximately real time display of the ROI.
- All x-ray fluoroscopic systems provide real-time video.
- One such system that is capable of providing such images in CT is a system called Smart Prep manufactured by General Electric of Milwaukee, Wis.
- a scan is repeated periodically after a small delay. A delay of approximately eight seconds is of short enough duration to provide satisfactory results.
- the concentration of the contrast in the ROI's is measured on each scan and plotted for the operator. In the General Electric system, this plot is used to help the operator decide when to begin scanning the organ.
- a mechanism similar to GE's may also be used as the sensor input to the ECS to automatically control the flow rate or concentrations.
- Another way in which the system of the present invention can use the resulting image for adjusting the injection parameters is for the operator to select two areas of interest on the image.
- the system produces a relative pixel intensity measurement by calculating the difference in pixel intensity between the two different areas.
- the operator selects one area located in the background and second area located within part of the patient being examined such as a blood vessel of interest.
- the image processor calculates the appropriate concentration of contrast media based upon the resulting measurement.
- FIG. 8 A further embodiment of the present invention is disclosed in FIG. 8 .
- the injection system is shown generally at 170 .
- the ECS 54 is connected to the contrast delivery system 172 and an embodiment of a Tactile Feedback Control (TFC) unit 173 .
- TFC Tactile Feedback Control
- An additional connection is made between the ECS and the user display 176 .
- the TFC 173 comprises a disposable syringe 174 which is located within a durable/reusable cradle 178 .
- the cradle 178 is electrically connected to the ECS 54 and is physically connected to a sliding potentiometer 180 which is driven by plunger 181 .
- the doctor holds the cradle and syringe during the injection procedure and as the doctor depresses the sliding potentiometer/syringe piston assembly, the plunger is moved forward, displacing fluid toward the patient and creating a pressure in the syringe.
- the sliding potentiometer 180 tracks the position of the syringe plunger.
- optical encoders could be used to prevent contact skipping thus increasing the system reliability.
- the ECS controls the Contrast Delivery System (CDS) to inject an amount of fluid into the patient based on the change in position of the plunger.
- CDS Contrast Delivery System
- the disposable syringe 174 is in fluid communication with a multi-port stopcock 182 .
- the pressure the doctor feels in his hand is proportional to the actual pressure produced by the contrast delivery system.
- the force required to move the piston provides the operator with tactile feedback on the pressure in the system. The doctor is able to use this feedback to ensure the safety of the injection procedure.
- the ECS may employ other pressure measurement mechanisms such as the contrast delivery system motor drive current.
- the ECS also incorporates preprogrammed flow rate and pressure limits which prevent the pressure of the injection from exceeding safe limits. Additionally, the user display 176 incorporates warning lights which indicate when certain pressure levels have been exceeded as well as an indication of the actual pressure.
- the ECS of the preferred embodiment of the present invention also stores the injection parameters or flow rate profiles used by individual doctors or other system operators so that the system is able to customize injection procedures to match the particular injection profile preferred by the individual. It has been recognized that doctors have varying preferences in the images used for diagnosing patients during medical imaging procedures. Varying degrees of contrast media concentration and injection rates alter the contrast in the resultant image. The system would be able to use information on a doctor's preference to customize procedures primarily based on the type of procedure and the weight of the patient. These and other injection statistics would be stored and after a sufficient sample size was available in system memory for the particular doctor or system operator, the system would make minor adjustments to the weight given to variables in the injection parameter calculation algorithm used by the ECS. This would enable the system to operate in the more automatic modes illustrated in FIGS. 2, 4 , or 5 .
- FIG. 9 illustrates the embodiment of the present invention disclosed in FIG. 8 , wherein the operator 162 is able to adjust flow rate via the Tactile Feedback Control unit (TFC) 174 .
- the operator is able to feel the actual pressure used during the injection procedure and is able to adjust flow rate based on the resultant image displayed on the video monitor 163 .
- the system incorporates pressure limitations to prevent patient injury. This system is similar to that shown in FIG. 7 , except that the operator views the region of interest, and pushes on the TFC in proportion to the amount of contrast media desired to be injected based on the resulting image.
- the doctor receives pressure feedback via the hand held unit.
- FIG. 10 a illustrates use of another embodiment of the present invention wherein the ECS uses signals generated in the TFC 190 to determine a proportionate amount of fluid to be injected into the patient.
- displacement is proportional to the actual amount of fluid delivered and the TFC is not in fluid communication with the fluid being delivered.
- FIG. 10 b shows more details of the TFC unit disclosed in FIG. 10 a which would eliminate the fluid path connection between the TFC and the actual fluid being injected.
- It consists of a plunger 200 with a threaded section 201 .
- the base consists of an outside case 205 , a pressure sensor 207 attached to the case, and a motor 209 , the base of which is attached through the pressure sensor 207 to the base of the case 205 .
- the shaft of the motor is connected to a threaded rod 210 .
- the plunger 200 freely slides back and forth with respect to the base. The plunger 200 cannot rotate with respect to the base.
- On the end of the plunger nearest the base is a threaded section 201 .
- a linear potentiometer may be connected to the plunger to provide a resistance proportional to the position of the plunger in the base for measurement by the ECS.
- the TFC functions as a syringe.
- the doctor pushes on the plunger 200 , he generates a force which is sensed by the force sensor 207 .
- the output of this sensor is proportional to the force applied by the doctor.
- Various types of force sensors may be used such as, for example, a piezoelectric film or a stiff spring with a linear displacement potentiometer.
- the ECS receives the pressure signal, and generates a proportional pressure in the contrast delivery system (CDS).
- the ECS energizes the motor 209 which rotates the threaded cylinder 210 .
- the plunger moves toward the base as the fluid is being delivered to the patient, and the doctor is sensing a resistance force which is proportional to the pressure required to deliver the fluid.
- the TFC of FIG. 10 b provides several benefits. It is completely reusable, because it may be either sterilized or simply covered by a bag. The fluid path is simplified, and therefore less expensive, easier to install, fill and assure the removal of air. The TFC can be much farther from the patient thereby also allowing the doctor or operator to be farther from the radiation field and receive less X-ray radiation. Both the ratios between the applied force and pressure in the CDS and between flow rate and displacement rate can be varied electronically, whereas in the previously described TFC, the force was set by the diameter of the disposable syringe.
- the displacement of the TFC is proportional to the volume of fluid being injected, and the rate of fluid injection is proportional to the rate at which the plunger of the TFC is displaced.
- a second mode is described with a control system which is similar to that found in a variable speed drill. In this system, the flow rate of the injection is proportional to the displacement of the TFC. This mode is not the primary one but may be preferred by some operators.
- the simplest algorithm assumes a linear relationship between the TFC displacement and the volume injected or the flow rate being injected. Other relationships are possible. Some examples are given in FIGS. 11 a - 11 d .
- the syringe is actually connected to the fluid line therefore the pressure in the TFC is the same as that at the injection, and the force felt by the operator is controlled by the diameter of the syringe.
- the relationship between input at the TFC and output from the CDS can follow any of the relationships of FIG. 11 or many others as well. The relationship may be different for different operators. A strong man is likely to prefer a different relationship than a smaller woman.
- the system would be configured according to individual preferences and the operator could simply enter their name and password to set the desired preferences.
- FIG. 11 d describes a relationship that might be used to inflate a balloon for angioplasty.
- the pressure in the CDS would be increased in steps as the pressure in the TFC is increased.
- Another capability of this embodiment is to synchronize the CDS with an electrocardiogram signal.
- Present injectors can be programmed to inject a specific volume at specific flow rate and position relative to a marker on an electrocardiogram such as, for example, the R wave. These systems are preferred by some, but do not have the confidence of others. It is not possible for an operator to manually synchronize with the electrocardiogram signal, so they inject by hand at a constant rate. This practice results in a waste of contrast media because the fluid flows into vessels which are not being studied.
- a benefit of the TFC is that the operator now has the instantaneous control of the injection with feedback on pressure and flow rate.
- the CDS is able to synchronize with the electrocardiogram thus minimizing the use of contrast media thus saving cost and dose to the patient.
- FIG. 12 illustrates an enhanced version of the system which is designed for cardiology.
- CT computed tomography
- MR magnetic resonance
- cardiology the situation is different.
- cardiologists use a manually activated manifold with several three-way or four-way valves. These valves are used so a single fluid line can measure pressure, perform scout injections, and provide various fluids during manipulation of the catheter to get it into the proper vessel.
- the disposable manifolds 215 are operated by electronic solenoids or motors controlled by the ECS. Thus the whole sequence of the procedure is automated to a great extent.
- FIG. 13 provides additional detail.
- a sterile disposable manifold 215 is shown and is similar to those manufactured by North American Instrument Corporation of Glen Falls, N.Y. The only difference is that manifold 215 includes valve adaptor plugs 217 , 218 , 219 which mate with slots in quarter-turn solenoid heads 221 , 222 , 223 .
- valve adaptor plugs 217 , 218 , 219 which mate with slots in quarter-turn solenoid heads 221 , 222 , 223 .
- Mounting pins 225 and 226 located on the solenoid mounting case 227 mate with mounting holes 228 , 229 on the disposable manifold 215 to secure the manifold to the solenoid mounting case.
- the ECS controls the position of the quarter-turn solenoids 231 , 232 , 233 via control lines 235 , 236 , 237 .
- the quarter-turn solenoids are simple electromechanical devices which rotate ninety-degrees each time they are energized. In the described system, the solenoids need only rotate in a single direction because three successive energizations is the same as moving one quarter-turn in the opposite direction. It is also important that the system is capable of determining the position of the manifolds to ensure that this information is available when power is first turned on and also to verify that the valves move as commanded. Simple position sensors are utilized for this purpose and send signals to the ECS via sense lines 240 , 241 , and 242 . In a preferred embodiment the sensors are optical encoders for simplicity and reliability.
- a doctor may activate the manifold via any type of remote control such as hand switches, foot switches or verbally with the aid of voice recognition equipment. This last possibility is illustrated by FIG. 14 .
- the doctor could say, “scout injection,” and the ECS operating in conjunction with the voice recognition equipment 244 would set the valves to the proper position for that function. This would eliminate many of the separate actions which a doctor currently is required to perform in using currently available systems.
- An additional advantage is that a doctor using the system is able to operate the equipment while being physically further from the patient thus being able to avoid the damaging effects of the x-ray radiation.
- additional feedback relating to system operation may be provided to enhance system performance.
- the operator may receive audio feedback related to operational characteristics such as speed, volume injected or pressure. Tone of an audible signal could be used such that a higher pitch would indicate a higher speed, greater volume, or greater pressure.
- an audible click could be used to indicate injection of each milliliter of fluid or the click repetition rate could be proportional to the pressure.
- Audible feedback allows the operator to receive this information while the operator continues to monitor the patient or the image on the display 163 .
- the audio feedback is transmitted to the operator via an ear phone which is either hard wired or battery powered to eliminate an additional distraction in a busy room and to avoid the possibility of the patient becoming alarmed as a result of the audio signal.
- the additional feedback could be displayed on the video monitor 163 along with the patient image. Providing the additional feedback visually avoids the possible distraction of others and is particularly useful if it can be displayed without distracting the operator from viewing the patient image.
- One method of simultaneous display is the use of numbers on the monitor which indicate flow rate. A bar graph or a syringe outline which empties as the fluid is injected are other options.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pathology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Business, Economics & Management (AREA)
- Medicinal Chemistry (AREA)
- General Business, Economics & Management (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
This invention relates generally to the field of medical devices for delivering contrast media during medical diagnostic and therapeutic imaging procedures and more particularly, this invention relates to improved contrast media delivery systems and methods of use which allow adjustment of contrast media concentration and injection parameters either before or during an injection procedure to provide patient specific dosing of contrast media, thus decreasing the waste and cost of these procedures while increasing their efficiency.
Description
- This application is a Divisional Application of U.S. patent application Ser. No. 09/749,894, filed Dec. 29, 2000, which is a divisional of U.S. patent application Ser. No. 09/197,773, filed Nov. 23, 1998, now U.S. Pat. No. 6,385,483, which is a divisional of U.S. patent application Ser. No. 08/309,820, filed Sep. 21, 1994, now U.S. Pat. No. 5,840,026, the contents of all of which are incorporated herein by reference.
- This invention relates generally to the field of medical devices for delivering contrast media during medical diagnostic and therapeutic imaging procedures and more particularly, this invention relates to improved contrast media delivery systems and methods of use which allow adjustment of contrast media concentration and injection parameters either before or during an injection procedure to provide patient specific dosing of contrast media, thus decreasing the waste and cost of these procedures while increasing their efficiency.
- It is well recognized that the appropriate dose for many medications is related to the size and weight of the patient being treated. This is readily apparent in the difference between the recommended doses which most medications have for adults and children. The appropriate dose of contrast media for a given medical imaging procedure is equally dependent upon the size and weight of the patient being examined as well as other additional factors.
- Although differences in dosing requirements for medical imaging procedures have been recognized, conventional medical imaging procedures continue to use pre-set doses or standard delivery protocols for injecting contrast media during medical imaging procedures. Using fixed protocols for delivery simplifies the procedure, however, providing the same amount of contrast media to patients weighing between 100 and 200 pounds, for example, produces very different results in image contrast and quality. If the amount of contrast media used is adequate to obtain satisfactory imaging for the 200 pound person, then it is likely that the 100 pound person will receive more contrast media than necessary for the procedure to produce a diagnostic image. With high contrast costs, this is a waste of money as well as increased patient risk.
- Standard protocols are used primarily to minimize the potential for errors by hospital personnel and decrease the likelihood of having to repeat the procedure, an occurrence which requires that the patient be exposed to additional radiation and contrast media. Furthermore, in prior art contrast delivery systems, once a bottle of contrast media was opened for use on a patient it could not be used on another patient due to contamination considerations. Existing contrast delivery systems do not prevent the source of contrast media used for an injection from being contaminated with body fluids of the patient. The containers which supplied the contrast media were generally therefore all single use containers and, consequently, the entire container of contrast media was given to the patient being studied.
- Present protocols include delivery rate in volume per unit time. Usually the injection is at a constant flow rate or with one change between two fixed flow rates. However, physically, pressure drives fluid flow. Thus, present fluid delivery systems employ some type of servo to develop the pressure needed to deliver the programmed flow rate, up to some pressure limit. The pressure needed depends upon the viscosity of the fluid, the resistance of the fluid path, and the flow rate desired. This is considerably better than the older injector systems which controlled pressure at a set value, and let the flow rate vary.
- There are significant drawbacks to fluid delivery systems which are unable to adjust the concentration of contrast media and other injection parameters during an injection procedure. Many patients may receive more contrast media than is necessary to produce an image of diagnostic quality, while others may receive an amount of contrast media insufficient for producing a satisfactory image. Existing procedures also frequently result in waste of contrast media as well as the need for repeating the procedure because an image of diagnostic quality could not be produced.
- Some of the shortcomings of existing procedures have been addressed and resolved as described in application Ser. No. 08/144,162, titled “Total System for Contrast Delivery,” filed Oct. 28, 1993, now abandoned, and incorporated herein by reference. This application discloses a contrast media delivery system which provides a source of contrast media that is sufficiently isolated from a patient undergoing an imaging procedure that the source of contrast media may be used on additional patients without concern for contamination. Additionally, this system is capable of adjusting contrast media concentration and other injection parameters during an injection procedure.
- The system incorporates a source of contrast media and, if desired, a diluent. Each is sufficiently isolated from the patient to prevent contamination. The contrast media preferably has a concentration which is the highest that would be used in an injection procedure so that the operator may combine the contrast media with a diluent and select virtually any concentration of contrast media desired for any given procedure. The concentration of the contrast media injected into a patient may be varied during the injection procedure by varying the ratio of diluent to contrast media. Each patient therefore receives only the amount of contrast media necessary to provide a proper diagnostic image.
- It is recognized that this system will be much more versatile and useful if the operator is able to select and adjust contrast media concentration and other injection parameters based on patient information or feedback received during the injection imaging procedures. Additionally, this system would be more efficient if it were capable of automatically choosing the appropriate concentration and injection rate for a given patient. Even more utility and efficiency would be realized from a system that is capable of automatically adjusting concentration and other injection parameters during an injection procedure based on feedback related to the resultant image quality.
- Accordingly, it is an object of this invention to provide an improved contrast media delivery system which is capable of automatically varying the injection rate and concentration of contrast media given to a patient during an imaging procedure, based on information received either before or during the injection procedure.
- It is another object of the present invention to provide an improved contrast media delivery system which obtains and utilizes feedback information during the imaging procedure to automatically adjust the flow rate, volume and/or concentration of the contrast media into the patient if needed.
- It is a further object of this invention to provide a system which is capable of selecting the appropriate injection flow rate and concentration for a given patient based on patient information entered into the system.
- Numerous other objects and advantages of the present invention will become apparent from the following summary, drawings, and detailed description of the invention and its preferred embodiment.
- The invention includes apparatus and methods for medical contrast imaging and comprises embodiments which provide patient specific dosing of contrast media in a variety of medical imaging procedures, as opposed to fixed protocols. In this invention, the protocol variables are determined by the system and are dependent upon patient specific information supplied by the operator, and/or information measured by the contrast delivery system either prior to, or during the injection procedure. These apparatus and procedures disclosed herein apply to all of the systems disclosed and described in the application titled “Total System for Contrast Delivery”, Ser. No. 08/144,462, now abandoned. Further systems are described in which the system receives input from an operator to provide the appropriate adjustment of system parameters.
- In a principal embodiment, information specific to any given patient is entered into the system and the appropriate concentration and injection parameters are computed before initiating the imaging fluid injection procedure. The system is then ready for injection of a patient. It is important to note that the system is not limited to choosing a particular concentration of contrast media or injection rate for the entire procedure, or even a moderate number of phases with constant velocity as present injectors can now do, but rather is capable of selecting an injection profile which may include a continuously varying injection rate and/or concentration of contrast media. The particular injection profile selected by the system is designed to provide the best image quality for the particular patient based on a variety of factors such as patient weight and circulation system variables.
- In a refined version of the system, feedback from at least one sensor is employed by the control system to modify the concentration of the contrast media, injection rate, and/or total volume during the injection procedure. Various types of sensors are disclosed for use with this system, in particular, various electromagnetic sensors or video monitoring devices provide feedback for the system or operator to use. In angiography, where the contrast is injected into the region of interest, the sensor needs to make a measurement in that region of interest. In CT and MR it is sufficient for the sensor to measure a remote area of the body, although measuring within the region of interest (ROI) could be advantageous in some applications. The sensor provides an indication of the actual amount of contrast media in the patient. This is used to calculate the appropriate injection rate or concentration of contrast media to provide a diagnostic image with minimum risk and cost.
- In critical locations such as coronary arteries, it will take a while for doctors to have confidence in automatically controlled fluid delivery system, thus, rather than automatically altering injection parameters based on feedback signals received from automatic sensors, the concentration, or other injection parameters may be manually adjusted based on images seen by the doctor or operator.
- A final version of the invention is disclosed which works to further improve doctors confidence by providing tactile feedback to a doctor or operator in addition to visual or other sensed feedback on the amount of contrast media in a patient. This provides the operator with additional information to use in determining injection rate, concentration and pressure for the injection procedure.
-
FIG. 1 is a flow diagram illustrating the prior art procedure for implementing a standard protocol. -
FIG. 2 is a flow diagram for a system of the present invention in which injection parameters are calculated based on patient specific information. -
FIG. 3 a illustrates an embodiment of the present invention which employs the improved procedure for calculating injection parameters of the present invention. -
FIG. 3 b illustrates an embodiment of the present invention which employs the improved procedure for calculating the filling of a syringe used with an injector. -
FIG. 4 is a flow diagram outlining an injection procedure which incorporates a sensor for sensing contrast concentration in a patient during a test injection. -
FIG. 5 is a flow diagram outlining an injection procedure which incorporates a sensor for sensing contrast concentration in a patient for modifying the injection parameters throughout the injection. -
FIG. 6 illustrates an example of a sensor for use with the present invention. -
FIG. 7 illustrates the present invention wherein the system is able to automatically adjust fluid flow rate based on the resulting image. -
FIG. 8 illustrates an embodiment of a tactile feedback pressure measurement device which allows the system operator to adjust injection parameters based on tactile feedback. -
FIG. 9 illustrates an embodiment of the present invention which incorporates a Tactile Feedback Control (TFC) unit which allows the system operator to adjust injection parameters based on this sensor as well as the resulting image. The TFC is in fluid communication with the fluid being injected. -
FIG. 10 a illustrates an embodiment of the present invention which incorporates a Tactile Feedback Control (TFC) unit which allows the system operator to adjust injection parameters based on this sensor as well as the resulting image. The TFC is not in fluid communication with the fluid being injected. -
FIG. 10 b illustrates an embodiment of the TFC in greater detail. -
FIGS. 11 a-d illustrate various relationships between TFC inputs and contrast delivery system actions which an operator could select with the system. -
FIG. 12 illustrates disposable manifolds operated by electronic solenoids or motors which are designed for use with the present invention during cardiology. -
FIG. 13 illustrates a manifold for use with the present invention during cardiology procedures. -
FIG. 14 illustrates a system by which the manifold illustrated inFIG. 13 is voice-activated. -
FIG. 1 is a flow diagram showing a conventional medical imaging procedure for implementation of a standard protocol. This diagram is indicated generally by the numeral 10. The imaging procedure standard protocol is selected at firstoperative step 11, and a decision is made atstep 12 as to whether the patient's weight is within a broad range considered to be appropriate for the particular concentration of contrast media and set of injection parameters for the selected protocol. If the patient's weight is within the broad range of weights acceptable for the particular contrast media and set of injection parameters, the standard protocol is determined to be appropriate atstep 14. The patient is injected and the image is acquired atstep 18. Alternatively, if the weight of the patient is not within the given range, an alternate contrast media concentration and set of injection parameters are chosen atstep 16. Once the alternate concentration or set of injection parameters are chosen atstep 16, the patient is then injected and the image is acquired atstep 18. The operator then reviews the image atstep 20. If the image is satisfactory, the procedure is successfully completed and the system is prepared for the next imaging procedure with this patient or another patient atstep 22. - If the image is not satisfactory, the procedure must be repeated as noted at
step 24. A decision is then made as to whether there is a specific problem with the system or selected protocol atstep 26. If there is a problem with the protocol, the selected protocol is revised atstep 28. Alternatively, if the initially selected protocol is appropriate,step 14 is repeated and the patient is injected atstep 18. As noted, this type of system and its lack of versatility has significant disadvantages compared with the system of the present invention. - The present invention takes advantage of the increased versatility of the advances set forth in the co-pending application previously noted and further advances the art by adding automatic functions and increased versatility.
- A flow-diagram illustrating an improved contrast media delivery of the present invention is shown generally by the numeral 30 in
FIG. 2 . In this system the operator initially inputs information relating to the patient such as size and weight in addition to other factors related to the particular imaging procedure being performed at firstoperative step 32. This information could be stored in a hospital computer and simply downloaded to the imaging system. The Electronic Control System (ECS) of the contrast media delivery system then determines the appropriate concentration of the contrast media and other injection parameters such as flow rates, volume, time delay, etc. atstep 34. The computed concentration of contrast media and injection parameters are then displayed atstep 36. - In this and other embodiments, the step of displaying parameters for user review is optional. As this capability is first introduced, operators will want to retain control. As they become familiar with the equipment and gain confidence with it, it will be possible to manufacture and market systems which no longer display injection parameters for operator review. In the preferred embodiment, however, the system operator then reviews the calculated parameters at
step 38 and decides whether to manually modify the parameters atstep 40 or proceed with the injection of the patient atstep 42. The injection begins instep 42, the image is acquired, and the system operator or physician reviews the resulting image atstep 44. If the image is satisfactory for diagnosis, the image is stored and the procedure is complete. The system may be prepared for the next imaging procedure atstep 46. Prior to preparing the system for the next imaging procedure, the operator may choose to performoptional step 47 in which the operator may input information to modify the algorithm which determines the injection parameters so that before the system stores the parameters they are set to levels which would have provided an image which is mote personally satisfactory. The system software keeps track of the various injection parameters a doctor or operator selects for patients of a particular size and for a given procedure. These factors are analyzed for preferred tendencies of the doctor or operator so that the system is able to select injection parameters based on the operators personal preferences. By performing this optional step, the system will be able to automatically select operating parameters which provide a more satisfactory image for an individual. If the operator chooses to performoptional step 47, the system is prepared for the next imaging procedure upon completion of this step. - Alternatively, if the image is not satisfactory, the image parameters are extracted at
step 48 and the ECS is updated atstep 49. The ECS then recalculates new parameters and repeatsstep 34. The remainder of the procedure is also repeated. It is anticipated that this will happen very seldom once the algorithm is adapted to the doctor's preference. -
FIG. 3 a illustrates an embodiment of the improved contrast media delivery system of the present invention generally at 50. The user interface of the ECS is indicated at 52 with direct connection to theECS 54. There is an additionalelectronic interface 56. Theelectronic interface 56 may be connected to other systems which are not shown, such as imaging equipment and the hospital information system. If this interface is connected to the hospital information system, it could rely on this system to receive patient specific information necessary for performing the procedure such as size, weight, etc. An operator would therefore only be required to input a patient number and the appropriate information would be downloaded from the hospital information system. - The
electronic interface 56 is also connected to theimaging equipment 57. The ECS is capable of sending and receiving information so that, for example, the operator only needs to program the CT scanner with the number of slices and section of the body being imaged. This would be transmitted to the contrast delivery system to be used in determining flow rates and delays, etc. Additionally, information relating to image quality or sensed concentration of contrast media is received to allow for automatic adjustment of the system. - An
information scanner 58 is also shown with direct connection to theECS 54. Theinformation scanner 58 scans information encoded and attached to fluid storage tanks for thecontrast container 60 anddiluent container 62. The information encoded and read by thescanner 58 includes information such as tank volume, type and concentration of fluid etc. This information is then employed by the ECS in controlling and calculating the implementation of the imaging procedure. Alternatively, this information is downloaded from memory located on a fluid delivery module as noted in the application titled Closed Loop Information Path for Medical Fluid Delivery Systems, Application Serial Number 08/273,665, filed Jul. 12, 1994, now abandoned. - Contrast and diluent tank volume, type and concentration of fluid is stored in the system memory and is updated after using the system. The system is therefore able to automatically warn the operator when the system is running low on contrast or diluent. Additionally, the system is able to warn the operator if the wrong contrast media was connected for a particular procedure.
- The
ECS 54 is also connected to respective contrast anddiluent heaters ECS 54 controls theheaters ECS 54 which also controls fluid flow of contrast and diluent through the pumps. - The output of each of the metering pumps 68, 69 is connected to the helical vane
static mixer 71 which ensures that the desired concentration of contrast media is produced by the system. Abackflow valve 73 in the fluid flow path to the patient prevents the contrast media from returning to the sources of contrast and diluent 60, 62 and causing contamination. Afluid assurance sensor 75 is also directly connected to theECS 54. The final element in the fluid path which is connected to theECS 54 is the pressurizingpump 76. The pressurizingpump 76 provides the desired injection rate of contrast media for the particular procedure. A perpatient connector 77 is followed by asterile filter 78 which is also connected in line to prevent contamination of the sources of contrast media and diluent by preventing body fluids of the patient from flowing back into the sources of contrast and diluent. The fluid path then flows throughconnector tube 80 and amedical stopcock 82. - A hand held
syringe 84 is also connected to a port of the stopcock 82 to allow the doctor to perform what are considered test or scout injections. For example, the doctor may get a small amount of fluid at a concentration, and then do hand powered injections during his manipulations to get a catheter into the proper vessel. In a preferred embodiment, a contrast media sensor (not shown) is added to the system to provide additional feedback during an injection procedure in order to provide for better monitoring of concentration as it is adjusted by the system. -
FIG. 3 b illustrates a second embodiment of the improved contrast media delivery system of the present invention generally at 50. Most of the system components and their function are identical to those ofFIG. 3 a, but instead of the perpatient connector 77,sterile filter 78,tubing 80,connector 82 andhand syringe 84, 3 b has asyringe 79 which is filled with fluid. This syringe is then placed in an injector for delivery of the fluid to the patient. Prevention of contamination is accomplished by having the syringe allowed to be filled only once. The label printer prints the patient specific injection information, and this label is then read by the ECS of the injector. Theinjector ECS 35 can utilize any of the improved patient specific processes of this invention, such as sensors or tactile feedback controllers, neither of which are shown. - Alternatively, the
injector ECS 35 could communicate with the fillingstation ECS 54 so that the injector is programmed by the filling station. A third alternative involves having the fillingstation user interface 52 display the injector parameters and then the operator enters these parameters intoinjector ECS 35 via the injector user interface. An advantage of this most manual system is that it can work with present injector equipment, enabling the customer to achieve patient specific dosing while utilizing equipment which he has already purchased. - One embodiment, not shown, that uses even less hardware and sophistication consists of only a user interface and an electronic control system. The operator enters the patient specific data, and the volume, concentration and injection parameters are displayed for the operator. Then the operator manually fills the syringe using a manual method, such as that supplied by NAMIC, of Glens Falls, N.Y., preserving any unused contrast for the next patient. The injector is then automatically or manually programmed according to the patient specific parameters computed, and is ready to inject.
- It will be appreciated that various devices could be employed to function as the
ECS 54.ECS 54 at the very least must incorporate a microprocessor and memory along with control outputs for the various devices. It is understood that software controls the system. The software relies on a variety of factors for calculating the appropriate contrast media concentration and injection parameters for a particular patient. - The appropriate weight given to each of the factors in the software for calculating these parameters cannot now be disclosed because of the varied relationship between these factors and the numerous imaging systems and sensors which may use this invention. It is contemplated that experimentation with various weight factors applied to the variables will provide the best results with any given system. This is why embodiments are described with varying degrees of operator control, operator verification and automatic operation.
- The following table provides an outline of the factors which the system may consider in evaluating the appropriate concentration of contrast media and injection rate for a particular patient as well as the general effect an increase in these factors would have on calculation of the injection parameters. Some factors such as weight have a continuous effect. A slightly heavier patient gets a little more contrast. Others, such as hydration or kidney function have no effect until some threshold is crossed.
TABLE I INPUT PARAMETER EFFECTED PARAMETER EFFECT FOR INTRA VENOUS Patient Weight Total volume Increases (mg of Iodine) Flow rate to get Increases mgl/kg/sec Concentration (optional) Increases Patient Hydration Concentration Increases Kidney Function Use minimum total mgl if poor or questionable Cardiac Status With poor status, use minimum total fluid volume to minimize fluid loading Circulation Transit Use longer delay time Time until start of scanner if circulation time is poor Change from single phase to multi-phase or continuously varying Length of Scanning Flow rate Decreases to lengthen image contrast time Connector tube Provides limit to prevent diameter or catheter over pressure size Patient vein status If weak, use lower concentration, lower FOR INTRA ARTERIAL Vessel Diameter Flow rate Increases Volume of Injection Increases Concentration Increases Catheter Diameter Concentration Increases Procedure/body Duration of injection Varies location Patient Weight Limit on total iodine Increases dose - Given the variety of factors to be considered, fuzzy logic or neural networks may be appropriate for implementation of the program, however, a conventional computer program also provides satisfactory results.
-
FIG. 4 illustrates a flow-chart of the injection procedure of the present invention with sensor measurement. In this procedure, a test injection is made and a contrast media sensor is used to provide feedback on the actual concentration of contrast media within the patient. Initially, the operator enters the type of imaging procedure to be performed and patient information at firstoperative step 90. It is important to note the system will already be aware of the type and concentration of the fluid available in the system tanks because the information scanner would have input this information when the tanks were installed. In thenext step 92, the ECS computes the appropriate concentration of contrast media and the injection parameters such as flow rates, volume, and time delay etc. The resultant concentration and injection parameters are then displayed atstep 94. The operator then reviews the parameters and decides whether to manually modify the procedure atstep 96. - If the operator is satisfied with the injection parameters, a test injection of the patient is performed in
step 98. Alternatively, the operator may modify the procedure instep 100 and then perform a test injection of the patient atstep 98. A sensor measurement of the concentration of contrast media within the patient's body is then performed atstep 102 and a decision is made atstep 104 as to whether the results of the sample injection are sufficiently close to the desired value. If the results of the test injection are not satisfactory, the system returns to step 100 to modify the injection parameters, either manually or automatically and then repeats the test injection atstep 98. - When the results of the test injection are satisfactory, the final injection parameters are selected at
step 106 which may involve having the operator fine tune the procedure by making minor adjustments and updating specific parameters to provide more desirable results. If more significant changes are needed, the test injection should be repeated as noted. The imaging injection procedure begins atstep 108. Upon completion of theinjection procedure step 108, the operator reviews the image atstep 110 and determines whether the procedure produced a satisfactory diagnostic image. If the image is satisfactory, the procedure is complete and the system may be prepared for the next imaging procedure atstep 112. Step 113 is an optional step which may be performed before preparing the system for the next imaging procedure if the operator wishes to update the algorithm which determines the injection parameters that are used to customize injection procedure to a doctor's preference. - Alternatively, if the image is unsatisfactory, the image parameters are extracted at
step 114 and the ECS injection parameters are updated atstep 115. The procedure is repeated beginning with recalculation of the injection parameters step 92. It is anticipated that this will happen very seldom once the algorithm has been adapted to the imaging equipment and the doctor's preferences as previously noted. -
FIG. 5 illustrates an alternate procedure for performing an imaging procedure with the improved contrast delivery system of the present invention. In this procedure, a sensor measurement is used throughout the injection procedure to provide an indication of the actual concentration of contrast media within the patient. Initially, information relating to the particular imaging procedure to be performed and patient are input to the system at step firstoperative step 116. The ECS computes concentration, and other injection parameters such as flow rates, volume, time delay, etc. atstep 117. The calculated concentration of contrast media and other injection parameters are then displayed atstep 119 and the operator reviews the calculated results and determines whether they are satisfactory atstep 120. If the results appear to be within the desired range, injection of the contrast media begins instep 122. - Alternatively, the operator may modify the injection parameters at
step 123 before initiating the injection atstep 122. A sensor measurement is made atstep 125 and a decision is made as to whether the results are satisfactory atstep 126. If they are not satisfactory, the injection parameters are modified atstep 127 and the sensor measurement is continued atstep 125. The sensor measurement is made and the injection parameters are adjusted throughout the injection process based on the sensor measurements. The adjustments continue until the procedure is complete as indicated atstep 128. If the sensor measurement indicates a serious problem, the system may automatically stop the injection procedure depending on the severity of the problem. Upon completion, the operator then reviews the image atstep 130 and decides whether the results are satisfactory. - If satisfactory results are achieved, the system is prepared for the next imaging procedure as indicated at
step 132. Step 133 is an optional step which may be performed before preparing the system for the next imaging procedure if the operator wishes to update the algorithm which determines the injection parameters to customize the injection procedure to a doctor's preference. - Alternatively, if the results are not satisfactory, the image parameters are extracted at
step 134 and the ECS injection parameters are updated atstep 136. The ECS then recalculates the concentration of contrast media and injection parameters atstep 117 and the operator repeats remaining steps in the procedure. Again, this will be a seldom occurrence once the doctor's preferences have been included. In this embodiment and all others, the repeat procedure may need to be postponed if the patient is near the maximum daily contrast dose. - Having the sensor provide to the ECS, a measure of contrast in the body during an injection and having the ECS be able to continuously adjust fluid concentration, flow rate, and/or timing of the signals to start the imaging equipment provides an ability to optimally adapt the dosing to patient specific parameters which may be unknown or inaccurately estimated before the start of the injection. For example, in a CT injection, contrast may arrive at a site more quickly in some patients than others.
- Systems are available which allow the operator to adjust the timing of the beginning of CT scans, however, these systems, unlike the systems of the present invention, are unable to adjust the flow rate, concentration, and/or stop the injection sooner than originally planned, thus limiting the amount of contrast injected into the patient, saving money and reducing patient risk.
-
FIG. 6 illustrates an example of a sensor which can be used with the improved contrast media injection system of the present invention. The sensor is shown generally at 140. It is contemplated that a variety of sensors may be used for evaluating the concentration of contrast media within a patient at particular time. These sensors use various wavelengths of electromagnetic radiation to determine the presence of contrast media. The particular sensor disclosed inFIG. 6 is designed for sensing contrast media used during procedures which use x-rays to create the desired image. Therefore this sensor employs a source of x-rays and a receiver for determining the amount of x-ray radiation which passes through the tissue of a patient. It is understood that use of other sensors for x-ray or different types of contrast media could be used in a similar manner. - The sensor includes a silicon
diode radiation detector 142 and source ofradioactive material 144. Amoveable shield 146 is capable of alternately shielding and exposing theradioactive material 144 to theradiation detector 142.Electronic actuator 148 moves theshield 146 upon command from the ECS. The sensor includes control andpower cables 150 connected to the ECS not shown. It has been found that a small radioactive source works best. One example of a commercially available product which can be used to generate an output which varies depending upon the level of x-rays passing through body tissue is the Lixi scope manufactured by Lixi, Inc. of Downers Grove, Ill. 60515. This product uses a similar design for portable imaging of small body parts such as the hand or ankle. Although this product is designed for producing images, it is also capable of being adapted to provide signals which are proportional to the level of contrast media in a patient. When used with the system of the present invention, the source and detector are placed on opposite sides of a thin tissue region such as the ear lobe, finger tip, or fleshy part of the hand between the thumb and index finger. It is known that the attenuation of the tissue will change as the concentration of x-ray contrast builds up in the blood and then surrounding tissue. It should be noted that the radioactive source should be shielded when not in use. - Another type of sensor which could be used with the system is one which employs visible or infrared (IR) light, preferably of two different wavelengths. This is similar to the technique currently employed in pulse oximeters. It is known that iodinated contrast interferes with the signals used to make oxygen measurements with pulse oximeters and that these systems are capable of measuring the level of iodinated contrast. Most x-ray contrasts contain a benzene ring with three iodine atoms attached at
positions 1, 3 and 5. Various organic molecules are attached atpositions 2, 4 and 6. The infrared spectrum for iodine atoms bonded to a benzene ring is unlike those for naturally occurring compounds. Dual or multiple wavelengths help to minimize interference or prevent positioning differences from giving incorrect readings. Sensors with other visible, IR or different electromagnetic wavelengths would be used for MRI or ultrasound contrast materials. - Another sensor which could be used with the improved injection system of the present invention is a pressure sensor inserted into a vessel. A tiny pressure sensor on an IC, such as those made by SenSim, Inc., Sunnyvale, Calif., are capable of providing this type of feedback. A dual lumen catheter and a conventional blood pressure monitor could be also used. During the injection procedure, the flow rate of the injector would be adjusted based upon the sensed intra-luminal pressure. For intravenous injections, the pressure within the vein could be used to limit or appropriately adjust flow rate or concentration to prevent vessel damage or extravasation. For intra-arterial injections, appropriate adjustment would minimize backflow by timing variations in flow rate to match internal variations due to pressure waves created by the heart. When backflow occurs, some of the injected contrast moves upstream in the vessel and may go to unintended side vessels. This is not usually dangerous, but does represent a waste of contrast. Measuring the pressure at one or more places in the artery or vein during injection provides the information which is necessary to safely inject the optimum amount of contrast.
- Regardless of the type of sensor used by the system, it is contemplated that the sensor will send a feedback signal to the ECS such as a voltage proportional to the concentration of contrast media present in a patient. The system could then either provide this information to the system operator for manual adjustment of the injection parameters, or alternatively, the system could use these signals to automatically adjust the concentration of the contrast media or the flow rate to provide a more desirable image. For intra-arterial, the delay between change in injection parameter and effect is small enough so that the operator may be part of the feedback loop. For intravenous injections, the delay is longer and variable, so having the ECS measure and automatically account for the delay is preferable.
-
FIG. 7 illustrates another embodiment of the present invention. In this embodiment, the system is capable of automatically adjusting the injection parameters to alter the image produced by the system based upon feedback from the actual image. This embodiment includes animage processor 160 which analyzes a bitmap of the video image produced by the contrast delivery system in conjunction with theimaging equipment 57. Theoperator 162 selects one area of interest on the image via themonitor 163, for example, by moving a box or pointer over the area via a user interface such as a mouse and then selecting the position by clicking the mouse. The user selects a desired area of interest such as a blood vessel being examined. Theimage processor 160 then calculates the average intensity of the pixels in the designated area. It is understood that pixel intensity would be proportional to the amount of contrast media in the patient's body due to the effect on the electromagnetic wave or ultrasonic energy wave being used for the imaging procedure. Depending upon the resultant average pixel intensity, the system then makes appropriate adjustments in contrast concentration and injection rate. - The use of a video image for providing feedback to make adjustments to the injection parameters requires real time or approximately real time display of the ROI. All x-ray fluoroscopic systems provide real-time video. One such system that is capable of providing such images in CT is a system called Smart Prep manufactured by General Electric of Milwaukee, Wis. Once the injection is started with this system, a scan is repeated periodically after a small delay. A delay of approximately eight seconds is of short enough duration to provide satisfactory results. The concentration of the contrast in the ROI's is measured on each scan and plotted for the operator. In the General Electric system, this plot is used to help the operator decide when to begin scanning the organ. In the invention described herein, a mechanism similar to GE's may also be used as the sensor input to the ECS to automatically control the flow rate or concentrations.
- Another way in which the system of the present invention can use the resulting image for adjusting the injection parameters is for the operator to select two areas of interest on the image. The system produces a relative pixel intensity measurement by calculating the difference in pixel intensity between the two different areas. The operator selects one area located in the background and second area located within part of the patient being examined such as a blood vessel of interest. The image processor calculates the appropriate concentration of contrast media based upon the resulting measurement.
- A further embodiment of the present invention is disclosed in
FIG. 8 . The injection system is shown generally at 170. TheECS 54 is connected to thecontrast delivery system 172 and an embodiment of a Tactile Feedback Control (TFC)unit 173. An additional connection is made between the ECS and theuser display 176. TheTFC 173 comprises adisposable syringe 174 which is located within a durable/reusable cradle 178. Thecradle 178 is electrically connected to theECS 54 and is physically connected to a slidingpotentiometer 180 which is driven byplunger 181. - The doctor holds the cradle and syringe during the injection procedure and as the doctor depresses the sliding potentiometer/syringe piston assembly, the plunger is moved forward, displacing fluid toward the patient and creating a pressure in the syringe. The sliding
potentiometer 180 tracks the position of the syringe plunger. Alternatively, optical encoders could be used to prevent contact skipping thus increasing the system reliability. - The ECS controls the Contrast Delivery System (CDS) to inject an amount of fluid into the patient based on the change in position of the plunger. The
disposable syringe 174 is in fluid communication with amulti-port stopcock 182. As the fluid is injected, the pressure the doctor feels in his hand is proportional to the actual pressure produced by the contrast delivery system. The force required to move the piston provides the operator with tactile feedback on the pressure in the system. The doctor is able to use this feedback to ensure the safety of the injection procedure. Separate from this mechanism, the ECS may employ other pressure measurement mechanisms such as the contrast delivery system motor drive current. - The primary benefit over a totally manual injection is that the doctor is not required to develop the pressure and flow rate. He only develops the pressure and pushes some of the fluid. The required manual power output (pressure*flow rate) is decreased.
- The ECS also incorporates preprogrammed flow rate and pressure limits which prevent the pressure of the injection from exceeding safe limits. Additionally, the
user display 176 incorporates warning lights which indicate when certain pressure levels have been exceeded as well as an indication of the actual pressure. - The ECS of the preferred embodiment of the present invention also stores the injection parameters or flow rate profiles used by individual doctors or other system operators so that the system is able to customize injection procedures to match the particular injection profile preferred by the individual. It has been recognized that doctors have varying preferences in the images used for diagnosing patients during medical imaging procedures. Varying degrees of contrast media concentration and injection rates alter the contrast in the resultant image. The system would be able to use information on a doctor's preference to customize procedures primarily based on the type of procedure and the weight of the patient. These and other injection statistics would be stored and after a sufficient sample size was available in system memory for the particular doctor or system operator, the system would make minor adjustments to the weight given to variables in the injection parameter calculation algorithm used by the ECS. This would enable the system to operate in the more automatic modes illustrated in
FIGS. 2, 4 , or 5. -
FIG. 9 illustrates the embodiment of the present invention disclosed inFIG. 8 , wherein theoperator 162 is able to adjust flow rate via the Tactile Feedback Control unit (TFC) 174. The operator is able to feel the actual pressure used during the injection procedure and is able to adjust flow rate based on the resultant image displayed on thevideo monitor 163. The system incorporates pressure limitations to prevent patient injury. This system is similar to that shown inFIG. 7 , except that the operator views the region of interest, and pushes on the TFC in proportion to the amount of contrast media desired to be injected based on the resulting image. In addition to the feedback via the video image, the doctor receives pressure feedback via the hand held unit. Doctor are familiar with this type of feedback because it is similar to the situation encountered when a powered fluid delivery system is not used. This increases their confidence when using the system in critical areas such as coronary vessels. As the operators gain confidence in the safety and reliability of the system, it will be possible for the system operation to be more automatic as shown inFIGS. 2, 4 , 5, or 7. -
FIG. 10 a illustrates use of another embodiment of the present invention wherein the ECS uses signals generated in theTFC 190 to determine a proportionate amount of fluid to be injected into the patient. In this embodiment, displacement is proportional to the actual amount of fluid delivered and the TFC is not in fluid communication with the fluid being delivered. -
FIG. 10 b shows more details of the TFC unit disclosed inFIG. 10 a which would eliminate the fluid path connection between the TFC and the actual fluid being injected. It consists of aplunger 200 with a threadedsection 201. The base consists of anoutside case 205, apressure sensor 207 attached to the case, and amotor 209, the base of which is attached through thepressure sensor 207 to the base of thecase 205. The shaft of the motor is connected to a threadedrod 210. Theplunger 200 freely slides back and forth with respect to the base. Theplunger 200 cannot rotate with respect to the base. On the end of the plunger nearest the base is a threadedsection 201. As the threadedrod 210 rotates, theplunger 200 is moved in or out, depending upon the direction of rotation. If desired, a linear potentiometer may be connected to the plunger to provide a resistance proportional to the position of the plunger in the base for measurement by the ECS. - To the doctor, the TFC functions as a syringe. When the doctor pushes on the
plunger 200, he generates a force which is sensed by theforce sensor 207. The output of this sensor is proportional to the force applied by the doctor. Various types of force sensors may be used such as, for example, a piezoelectric film or a stiff spring with a linear displacement potentiometer. The ECS receives the pressure signal, and generates a proportional pressure in the contrast delivery system (CDS). As the fluid is delivered by the CDS, the ECS energizes themotor 209 which rotates the threadedcylinder 210. Thus the plunger moves toward the base as the fluid is being delivered to the patient, and the doctor is sensing a resistance force which is proportional to the pressure required to deliver the fluid. - The TFC of
FIG. 10 b provides several benefits. It is completely reusable, because it may be either sterilized or simply covered by a bag. The fluid path is simplified, and therefore less expensive, easier to install, fill and assure the removal of air. The TFC can be much farther from the patient thereby also allowing the doctor or operator to be farther from the radiation field and receive less X-ray radiation. Both the ratios between the applied force and pressure in the CDS and between flow rate and displacement rate can be varied electronically, whereas in the previously described TFC, the force was set by the diameter of the disposable syringe. - In either of the TFC embodiments shown in
FIGS. 8 and 10 b, it is possible to operate in several modes. In the preferred mode, the displacement of the TFC is proportional to the volume of fluid being injected, and the rate of fluid injection is proportional to the rate at which the plunger of the TFC is displaced. A second mode is described with a control system which is similar to that found in a variable speed drill. In this system, the flow rate of the injection is proportional to the displacement of the TFC. This mode is not the primary one but may be preferred by some operators. - The simplest algorithm assumes a linear relationship between the TFC displacement and the volume injected or the flow rate being injected. Other relationships are possible. Some examples are given in
FIGS. 11 a-11 d. In the TFC ofFIG. 8 , the syringe is actually connected to the fluid line therefore the pressure in the TFC is the same as that at the injection, and the force felt by the operator is controlled by the diameter of the syringe. In the electronically actuated TFC the relationship between input at the TFC and output from the CDS can follow any of the relationships ofFIG. 11 or many others as well. The relationship may be different for different operators. A strong man is likely to prefer a different relationship than a smaller woman. In a preferred embodiment, the system would be configured according to individual preferences and the operator could simply enter their name and password to set the desired preferences. - The example in
FIG. 11 d describes a relationship that might be used to inflate a balloon for angioplasty. The pressure in the CDS would be increased in steps as the pressure in the TFC is increased. - Another capability of this embodiment is to synchronize the CDS with an electrocardiogram signal. Present injectors can be programmed to inject a specific volume at specific flow rate and position relative to a marker on an electrocardiogram such as, for example, the R wave. These systems are preferred by some, but do not have the confidence of others. It is not possible for an operator to manually synchronize with the electrocardiogram signal, so they inject by hand at a constant rate. This practice results in a waste of contrast media because the fluid flows into vessels which are not being studied. A benefit of the TFC is that the operator now has the instantaneous control of the injection with feedback on pressure and flow rate. The CDS is able to synchronize with the electrocardiogram thus minimizing the use of contrast media thus saving cost and dose to the patient.
- The selected exemplary embodiments of the TFC units set forth above describe two design choices for the TFC. It is contemplated that various substitutions and modifications could be made to accomplish the results of the selected designs. The claims are in no way limited to these preferred embodiments.
-
FIG. 12 illustrates an enhanced version of the system which is designed for cardiology. In CT, MR and many angiographic procedures, the contrast injector does not share the fluid path to the patient with any other devices. In cardiology, the situation is different. Presently, cardiologists use a manually activated manifold with several three-way or four-way valves. These valves are used so a single fluid line can measure pressure, perform scout injections, and provide various fluids during manipulation of the catheter to get it into the proper vessel. In this embodiment of the invention, thedisposable manifolds 215 are operated by electronic solenoids or motors controlled by the ECS. Thus the whole sequence of the procedure is automated to a great extent. -
FIG. 13 provides additional detail. A steriledisposable manifold 215 is shown and is similar to those manufactured by North American Instrument Corporation of Glen Falls, N.Y. The only difference is thatmanifold 215 includes valve adaptor plugs 217, 218, 219 which mate with slots in quarter-turn solenoid heads 221, 222, 223. Although numerous mating geometries are possible, there is a safety advantage if mating may be accomplished in a single orientation. In the preferred embodiment described inFIG. 13 , a single orientation is assured by having slots located in the solenoid heads which are more narrow on one end than the other. Mountingpins solenoid mounting case 227 mate with mountingholes 228, 229 on thedisposable manifold 215 to secure the manifold to the solenoid mounting case. - The ECS controls the position of the quarter-turn solenoids 231, 232, 233 via
control lines sense lines - A doctor may activate the manifold via any type of remote control such as hand switches, foot switches or verbally with the aid of voice recognition equipment. This last possibility is illustrated by
FIG. 14 . There is a significant benefit in the ability of the doctor to activate a control for example by simply stating, “measure pressure,” and have all the valves move to the proper position. Alternatively, the doctor could say, “scout injection,” and the ECS operating in conjunction with thevoice recognition equipment 244 would set the valves to the proper position for that function. This would eliminate many of the separate actions which a doctor currently is required to perform in using currently available systems. An additional advantage is that a doctor using the system is able to operate the equipment while being physically further from the patient thus being able to avoid the damaging effects of the x-ray radiation. - In those embodiments where the operator is in the feedback loop, additional feedback relating to system operation may be provided to enhance system performance. For example, the operator may receive audio feedback related to operational characteristics such as speed, volume injected or pressure. Tone of an audible signal could be used such that a higher pitch would indicate a higher speed, greater volume, or greater pressure. Alternatively, an audible click could be used to indicate injection of each milliliter of fluid or the click repetition rate could be proportional to the pressure. Audible feedback allows the operator to receive this information while the operator continues to monitor the patient or the image on the
display 163. In a preferred embodiment, the audio feedback is transmitted to the operator via an ear phone which is either hard wired or battery powered to eliminate an additional distraction in a busy room and to avoid the possibility of the patient becoming alarmed as a result of the audio signal. - Alternatively, the additional feedback could be displayed on the
video monitor 163 along with the patient image. Providing the additional feedback visually avoids the possible distraction of others and is particularly useful if it can be displayed without distracting the operator from viewing the patient image. One method of simultaneous display is the use of numbers on the monitor which indicate flow rate. A bar graph or a syringe outline which empties as the fluid is injected are other options. - Although the present invention has been described in terms of preferred embodiments, the present description is given by way of example and is not intended to be limiting to the scope of the invention described and claimed herein.
Claims (32)
1-21. (canceled)
22. A method of delivering fluid media into a patient in connection with an imaging procedure, the method comprising the steps of:
(a) providing a media delivery system for injecting into the patient at least one of a contrast medium and a diluent;
(b) providing an imaging system for conducting the imaging procedure of a desired region of the patient through which the least one of the contrast medium and the diluent flows;
(c) providing an electronic interface for enabling the media delivery system to receive from the imaging system feedback in the form of an image of the desired region of the patient;
(d) providing the media delivery system with data characteristic of the patient for the purpose of calculating an initial set of injection parameters;
(e) injecting via the media delivery system at least one of the contrast medium and the diluent according to the initial set of injection parameters so calculated;
(f) acquiring via the imaging system one or more images of the desired region of the patient in accordance with the initial parameters;
(g) providing the feedback through the electronic interface from the imaging system to the media delivery system;
(h) adjusting the injection parameters via the media delivery system in accordance with the feedback obtained from the imaging system; and
(i) modifying the injection of at least one of the contrast medium and the diluent in accordance with the injection parameters so adjusted.
23. The method of claim 22 wherein the data characteristic of the patient includes at least one of size, weight, hydration, cardiac status, vessel type, vessel status, circulation transit time, and kidney function.
24. The method of claim 22 wherein the injection parameters include at least one of flow rate, concentration, volume, pressure, and time delay for administration of at least one of the contrast medium and the diluent.
25. The method of claim 22 wherein the step of calculating the initial set of injection parameters is based not only on the data characteristic of the patient but also on initial parameters particular to the imaging procedure to be performed.
26. The method of claim 22 further including, after the modifying step, the step of acquiring during the imaging procedure one or more additional images of the desired region of the patient, the additional images(s) acquired in connection with the adjusted injection parameters being of a quality better than the acquired in connection with the initial parameters.
27. The method of claim 22 wherein the media delivery system includes an electronic control means having a microprocessor, memory and associated software for permitting input of the data characteristic of the patient, for calculating the initial injection parameters based thereon, and for adjusting the injection parameters based on the feedback from the imaging system.
28. The method of claim 22 wherein the electronic interface also enables the media delivery system to receive the data characteristic of the patient from a separate information system.
29. The method of claim 28 wherein the separate information system is a hospital information system.
30. A method of delivering fluid media into a patient in connection with an imaging procedure, the method comprising the steps of:
(a) providing a media delivery system for injecting into the patient at least one of a contrast medium and a diluent;
(b) providing an imaging system for conducting the imaging procedure;
(c) providing a sensor for sensing concentration of the contrast medium within a desired region of the patient;
(d) providing an electronic interface for enabling the media delivery system to receive from the sensor feedback pertaining to the concentration of the contrast medium within the desired region of the patient;
(e) providing the media delivery system with data characteristic of the patient for the purpose of calculating an initial set of injection parameters;
(f) injecting via the media delivery system at least one of the contrast medium and the diluent according to the initial set of injection parameters so calculated;
(g) acquiring via the imaging system one or more images of the desired region of the patient in accordance with the initial parameters;
(h) providing the feedback from the sensor through the electronic interface to the media delivery system;
(i) adjusting the injection parameters via the media delivery system in accordance with the feedback obtained from the sensor; and
(j) modifying the injection of at least one of the contrast medium and the diluent in accordance with the injection parameters so adjusted.
31. The method of claim 30 wherein the data characteristic of the patient includes at least one of size, weight, hydration, cardiac status, vessel type, vessel status, circulation transit time, and kidney function.
32. The method of claim 30 wherein the injection parameters include at least one of flow rate, concentration, volume, pressure, and time delay for administration of at least one of the contrast medium and the diluent.
33. The method of claim 30 wherein the step of calculating the initial set of injection parameters is based not only on the data characteristic of the patient but also on initial parameters particular to the imaging procedure to be performed.
34. The method of claim 30 further including, after the modifying step, the step of acquiring one or more additional images of the desired region of the patient, the additional image(s) acquired in connection with the adjusted injection parameters being of a quality better than the images acquired in connection with the initial parameters.
35. The method of claim 30 wherein the media delivery system includes an electronic control means having a microprocessor, memory and associated software for permitting input of the data characteristic of the patient, for calculating the initial injection parameters based thereon, and for adjusting the injection parameters based on the feedback from the sensor.
36. The method of claim 30 wherein the electronic interface also enables the media delivery system to receive the data characteristic of the patient from a separate information system.
37. The method of claim 36 wherein the separate information system is a hospital information system.
38. A method of delivering fluid media into a patient, the method comprising the steps of:
(a) providing a media delivery system with data characteristic of the patient for the purpose of calculating an initial set of injection parameters in accordance with which at least one of a contrast medium and an other fluid is injected into the patient;
(b) acquiring during an imaging procedure one or more images of a desired region of the patient through which the least one of the contrast medium and the other fluid flows;
(c) providing to the media delivery system a signal representative of concentration of the contrast medium within the desired region of the patient;
(d) adjusting the injection parameters via the media delivery system in accordance with the signal representative of the concentration of the contrast medium within the desired region of the patient; and
(e) modifying the injection into the patient of at least one of the contrast medium and the other fluid in accordance with the injection parameters so adjusted.
39. The method of claim 38 wherein the data characteristic of the patient includes at least one of size, weight, hydration, cardiac status, vessel type, vessel status, circulation transit time, and kidney function.
40. The method of claim 38 wherein the injection parameters include at least one of flow rate, concentration, volume, pressure, and time delay for administration of at least one of the contrast medium and the other fluid.
41. The method of claim 38 wherein the step of calculating the initial set of injection parameters is based not only on the data characteristic of the patient but also on initial parameters particular to the imaging procedure to be performed.
42. The method of claim 38 wherein a sensor provides the signal representative of concentration of the contrast medium within the desired region of the patient.
43. The method of claim 42 wherein the sensor is an imaging system from which the signal is one or more of the images obtained during the imaging procedure.
44. The method of claim 42 wherein, for when the imaging procedure is one that employs x-rays, the sensor includes a source of x-rays and a receiver for determining an amount of x-ray radiation that passes through the desired region of the patient.
45. The method of claim 42 wherein the sensor employs electromagnetic radiation to determine concentration of the contrast medium within the desired region of the patient.
46. The method of claim 45 wherein the electromagnetic radiation takes the form of at least one of visible light and infrared light.
47. The method of claim 42 wherein the sensor employs pressure sensing within a vessel to determine concentration of the contrast medium within the desired region of the patient.
48. The method of claim 42 wherein the sensor provides the signal in the form of a voltage proportional to concentration of the contrast medium within the desired region of the patient.
49. The method of claim 38 further including, after the modifying step, the step of acquiring during the imaging procedure one or more additional images of the desired region of the patient, the additional image(s) acquired in connection with the adjusted injection parameters being of a quality better than the images acquired in connection with the initial parameters.
50. The method of claim 38 wherein the media delivery system includes an electronic control means having a microprocessor, memory and associated software for permitting input of the data characteristic of the patient, for calculating the initial injection parameters based thereon, and for adjusting the injection parameters based on the signal representative of concentration of the contrast medium within the desired region of the patient.
51. The method of claim 38 wherein the media delivery system includes an electronic interface to enable receipt of the data characteristic of the patient from a separate information system.
52. The method of claim 51 wherein the separate information system is a hospital information system.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/752,478 US20070282199A1 (en) | 1994-09-21 | 2007-05-23 | Methods of injecting fluids for use in imaging and therapeutic procedures where feedback enables adjustment of injection parameters |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/309,820 US5840026A (en) | 1994-09-21 | 1994-09-21 | Patient specific dosing contrast delivery systems and methods |
US09/197,773 US6385483B1 (en) | 1994-09-21 | 1998-11-23 | Patient specific dosing contrast delivery systems and methods |
US09/749,894 US6889074B2 (en) | 1994-09-21 | 2000-12-29 | Patient specific dosing contrast delivery systems and methods |
US10/775,235 US7313431B2 (en) | 1994-09-21 | 2004-02-11 | System and method for inflating a balloon catheter and delivering fluid media to a patient |
US11/752,478 US20070282199A1 (en) | 1994-09-21 | 2007-05-23 | Methods of injecting fluids for use in imaging and therapeutic procedures where feedback enables adjustment of injection parameters |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/775,235 Division US7313431B2 (en) | 1994-09-21 | 2004-02-11 | System and method for inflating a balloon catheter and delivering fluid media to a patient |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070282199A1 true US20070282199A1 (en) | 2007-12-06 |
Family
ID=23199802
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/309,820 Expired - Lifetime US5840026A (en) | 1994-09-21 | 1994-09-21 | Patient specific dosing contrast delivery systems and methods |
US09/197,773 Expired - Lifetime US6385483B1 (en) | 1994-09-21 | 1998-11-23 | Patient specific dosing contrast delivery systems and methods |
US09/749,894 Expired - Fee Related US6889074B2 (en) | 1994-09-21 | 2000-12-29 | Patient specific dosing contrast delivery systems and methods |
US10/139,995 Abandoned US20030050556A1 (en) | 1994-09-21 | 2002-05-06 | Patient specific dosing contrast delivery systems and methods |
US10/775,235 Expired - Fee Related US7313431B2 (en) | 1994-09-21 | 2004-02-11 | System and method for inflating a balloon catheter and delivering fluid media to a patient |
US11/752,451 Abandoned US20070225601A1 (en) | 1994-09-21 | 2007-05-23 | Injection systems capable of using feedback for adjustment of injection parameters |
US11/752,478 Abandoned US20070282199A1 (en) | 1994-09-21 | 2007-05-23 | Methods of injecting fluids for use in imaging and therapeutic procedures where feedback enables adjustment of injection parameters |
US11/842,325 Abandoned US20080045834A1 (en) | 1994-09-21 | 2007-08-21 | System and method for delivering fluids to a balloon catheter |
Family Applications Before (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/309,820 Expired - Lifetime US5840026A (en) | 1994-09-21 | 1994-09-21 | Patient specific dosing contrast delivery systems and methods |
US09/197,773 Expired - Lifetime US6385483B1 (en) | 1994-09-21 | 1998-11-23 | Patient specific dosing contrast delivery systems and methods |
US09/749,894 Expired - Fee Related US6889074B2 (en) | 1994-09-21 | 2000-12-29 | Patient specific dosing contrast delivery systems and methods |
US10/139,995 Abandoned US20030050556A1 (en) | 1994-09-21 | 2002-05-06 | Patient specific dosing contrast delivery systems and methods |
US10/775,235 Expired - Fee Related US7313431B2 (en) | 1994-09-21 | 2004-02-11 | System and method for inflating a balloon catheter and delivering fluid media to a patient |
US11/752,451 Abandoned US20070225601A1 (en) | 1994-09-21 | 2007-05-23 | Injection systems capable of using feedback for adjustment of injection parameters |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/842,325 Abandoned US20080045834A1 (en) | 1994-09-21 | 2007-08-21 | System and method for delivering fluids to a balloon catheter |
Country Status (3)
Country | Link |
---|---|
US (8) | US5840026A (en) |
EP (2) | EP0702966B1 (en) |
DE (1) | DE69530035T2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9289550B1 (en) | 2001-02-06 | 2016-03-22 | Bayer Healthcare Llc | Apparatus and method for detecting fluid extravasation |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
US9760830B2 (en) | 2011-12-28 | 2017-09-12 | Siemens Aktiengesellschaft | Control method and control system |
US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US9959389B2 (en) | 2010-06-24 | 2018-05-01 | Bayer Healthcare Llc | Modeling of pharmaceutical propagation and parameter generation for injection protocols |
US10166326B2 (en) | 2004-11-24 | 2019-01-01 | Bayer Healthcare Llc | Devices, systems and methods for determining parameters of one or more phases of an injection procedure |
US10722136B2 (en) | 2011-09-02 | 2020-07-28 | Battelle Memorial Institute | Wireless and power-source-free extravasation and infiltration detection sensor |
Families Citing this family (356)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5579767A (en) * | 1993-06-07 | 1996-12-03 | Prince; Martin R. | Method for imaging abdominal aorta and aortic aneurysms |
US5590654A (en) * | 1993-06-07 | 1997-01-07 | Prince; Martin R. | Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
EP1258262A3 (en) * | 1993-10-28 | 2002-12-18 | Medrad, Inc. | Total system for contrast delivery |
EP0650738B1 (en) * | 1993-10-28 | 2003-05-02 | Medrad, Inc. | Multi-patient fluid dispensing |
US5840026A (en) * | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
US6397098B1 (en) * | 1994-09-21 | 2002-05-28 | Medrad, Inc. | Data communication and control for medical imaging systems |
US8005530B2 (en) * | 1995-04-12 | 2011-08-23 | Prince Martin R | Method and apparatus for imaging abdominal aorta and aortic aneurysms |
US20030028145A1 (en) * | 1995-04-20 | 2003-02-06 | Duchon Douglas J. | Angiographic injector system with multiple processor redundancy |
US7267666B1 (en) | 1995-04-20 | 2007-09-11 | Acist Medical Systems, Inc. | Angiographic injector system with multiple processor redundancy |
WO1996032887A1 (en) * | 1995-04-20 | 1996-10-24 | Invasatec, Inc. | Radiographic contrast material injector |
US6656157B1 (en) * | 1995-04-20 | 2003-12-02 | Acist Medical Systems, Inc. | Infinitely refillable syringe |
US6099502A (en) * | 1995-04-20 | 2000-08-08 | Acist Medical Systems, Inc. | Dual port syringe |
US8082018B2 (en) * | 1995-04-20 | 2011-12-20 | Acist Medical Systems, Inc. | System and method for multiple injection procedures on heart vessels |
US5665065A (en) * | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
AUPN707195A0 (en) * | 1995-12-12 | 1996-01-11 | University Of Melbourne, The | Field programmable intravenous infusion system |
DE19647701A1 (en) * | 1996-11-08 | 1998-05-14 | Schering Ag | Device for obtaining constant densities of contrast media in tissues and organs |
JP4270748B2 (en) * | 1997-11-07 | 2009-06-03 | アシスト・メディカル・システムズ・インコーポレーテッド | Angiographic syringe apparatus with multiple processor redundancy |
US6726650B2 (en) * | 1997-12-04 | 2004-04-27 | Bracco Research S.A. | Automatic liquid injection system and method |
DE19756872B4 (en) * | 1997-12-19 | 2005-06-02 | Siemens Ag | Device for administering an infusion and / or perfusion to a patient |
US6743202B2 (en) | 1998-06-15 | 2004-06-01 | Medrad, Inc. | Encoding of syringe information |
US6113574A (en) * | 1998-07-27 | 2000-09-05 | Spinello; Ronald P. | Anesthetic injection apparatus and methods |
US6554798B1 (en) * | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
DE19840536A1 (en) | 1998-08-28 | 2000-03-09 | Schering Ag | Syringe filled with ultrasound contrast medium with a magnetic movement device |
DE19840532A1 (en) | 1998-08-28 | 2000-03-09 | Schering Ag | Syringe filled with ultrasound contrast medium with a mechanical movement device |
US6231560B1 (en) * | 1999-02-10 | 2001-05-15 | Baxter International Inc | Method and apparatus for automatically controlling the level of medication |
US6317623B1 (en) * | 1999-03-12 | 2001-11-13 | Medrad, Inc. | Apparatus and method for controlling contrast enhanced imaging procedures |
US6575930B1 (en) | 1999-03-12 | 2003-06-10 | Medrad, Inc. | Agitation devices and dispensing systems incorporating such agitation devices |
AU4185600A (en) * | 1999-04-01 | 2000-10-23 | Acist Medical Systems, Inc. | An integrated medical information management and medical device control system and method |
US6055985A (en) | 1999-04-09 | 2000-05-02 | B.H.B., L.C. | Methods for injecting a contrast medium to generate prolonged uniform vascular enhancement |
US6635030B1 (en) | 1999-04-09 | 2003-10-21 | B.H.B. Llc | Contrast injector for injecting a contrast medium to generate prolonged uniform vascular enhancement |
US6355024B1 (en) | 1999-07-14 | 2002-03-12 | Mallinckrodt Inc. | Medical fluid delivery system |
US6468261B1 (en) | 1999-07-14 | 2002-10-22 | Mallinckrodt Inc. | Medical fluid delivery system |
US6442415B1 (en) * | 1999-08-12 | 2002-08-27 | Magnetic Moments, L.L.C. | Contrast-enhanced coronary artery and coronary artery bypass graft imaging using an aortic root catheter injection with either magnetic resonance angiography or computed tomographic angiography |
AU6632600A (en) * | 1999-08-20 | 2001-03-19 | Acist Medical Systems, Inc. | Apparatus and method of detecting fluid |
US6876991B1 (en) | 1999-11-08 | 2005-04-05 | Collaborative Decision Platforms, Llc. | System, method and computer program product for a collaborative decision platform |
US6519569B1 (en) | 1999-12-01 | 2003-02-11 | B. Braun Medical, Inc. | Security infusion pump with bar code reader |
US7645258B2 (en) | 1999-12-01 | 2010-01-12 | B. Braun Medical, Inc. | Patient medication IV delivery pump with wireless communication to a hospital information management system |
US6790198B1 (en) | 1999-12-01 | 2004-09-14 | B-Braun Medical, Inc. | Patient medication IV delivery pump with wireless communication to a hospital information management system |
US6800075B2 (en) * | 1999-12-10 | 2004-10-05 | Sprite Solutions | Method to inject and extract fluid at a treatment site to remove debris |
US6669679B1 (en) | 2000-01-07 | 2003-12-30 | Acist Medical Systems, Inc. | Anti-recoil catheter |
US6626862B1 (en) * | 2000-04-04 | 2003-09-30 | Acist Medical Systems, Inc. | Fluid management and component detection system |
US6471674B1 (en) | 2000-04-21 | 2002-10-29 | Medrad, Inc. | Fluid delivery systems, injector systems and methods of fluid delivery |
US6673048B1 (en) | 2000-05-24 | 2004-01-06 | Acist Medical Systems, Inc. | Pressure sleeve assembly |
AUPQ867900A0 (en) | 2000-07-10 | 2000-08-03 | Medrad, Inc. | Medical injector system |
EP1301227B1 (en) * | 2000-07-20 | 2007-11-28 | ACIST Medical Systems, Inc. | Syringe plunger locking mechanism |
DE50006026D1 (en) * | 2000-08-01 | 2004-05-13 | Coripharm Medizinprodukte Gmbh | ACTIVE IMPLANT BLOCK SYSTEM AND METHOD FOR THE PRODUCTION THEREOF |
WO2005119025A2 (en) | 2004-06-01 | 2005-12-15 | Spectrum Dynamics Llc | Radioactive-emission-measurement optimization to specific body structures |
US8909325B2 (en) | 2000-08-21 | 2014-12-09 | Biosensors International Group, Ltd. | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
US8489176B1 (en) | 2000-08-21 | 2013-07-16 | Spectrum Dynamics Llc | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
US8565860B2 (en) | 2000-08-21 | 2013-10-22 | Biosensors International Group, Ltd. | Radioactive emission detector equipped with a position tracking system |
US6598466B1 (en) | 2000-10-05 | 2003-07-29 | Xerox Corporation | Method for additive adhesion force particle analysis and apparatus thereof |
US6508104B1 (en) | 2000-10-05 | 2003-01-21 | Xerox Corporation | Method for additive adhesion force particle analysis and apparatus thereof |
ES2205956B1 (en) * | 2000-10-16 | 2005-04-01 | Probitas Pharma S.A. | APPLIANCE FOR INFLATION AND DEFLATING OF CATHETERS WITH BALL AND PROCEDURE FOR USING THE SAME. |
US7094216B2 (en) | 2000-10-18 | 2006-08-22 | Medrad, Inc. | Injection system having a pressure isolation mechanism and/or a handheld controller |
US20020172323A1 (en) * | 2001-02-02 | 2002-11-21 | University Of Massachusetts Medical Center | Device for detection of extravasation |
AU2002240386A1 (en) * | 2001-02-14 | 2002-08-28 | Acist Medical Systems, Inc. | Catheter fluid control system |
US7566320B2 (en) * | 2001-02-14 | 2009-07-28 | Acist Medical Systems, Inc. | Fluid injector system |
US6969865B2 (en) * | 2001-02-15 | 2005-11-29 | Acist Medical Systems, Inc. | Systems and methods for detection and measurement of elements in a medium |
US7766894B2 (en) | 2001-02-15 | 2010-08-03 | Hansen Medical, Inc. | Coaxial catheter system |
US6699232B2 (en) * | 2001-03-01 | 2004-03-02 | Scimed Life Systems, Inc. | Fluid injection apparatus with improved contrast visualization |
US7044933B2 (en) * | 2001-03-01 | 2006-05-16 | Scimed Life Systems, Inc. | Fluid injection system for coronary intervention |
US8034026B2 (en) | 2001-05-18 | 2011-10-11 | Deka Products Limited Partnership | Infusion pump assembly |
MXPA03010576A (en) | 2001-05-18 | 2004-05-27 | Deka Products Lp | Infusion set for a fluid pump. |
JP3486615B2 (en) * | 2001-05-22 | 2004-01-13 | 畦元 将吾 | Region extraction method for medical images |
US7308300B2 (en) * | 2001-05-30 | 2007-12-11 | Acist Medical Systems, Inc. | Medical injection system |
US6597938B2 (en) * | 2001-08-16 | 2003-07-22 | Koninklijke Philips Electronics, N.V. | System for assistance of parameter determination and diagnosis in MRI dynamic uptake studies |
US6832200B2 (en) * | 2001-09-07 | 2004-12-14 | Hewlett-Packard Development Company, L.P. | Apparatus for closed-loop pharmaceutical delivery |
US7258681B2 (en) * | 2001-10-04 | 2007-08-21 | Scimed Life Systems, Inc. | Angiographic fluid control system |
US6918893B2 (en) | 2001-10-04 | 2005-07-19 | Scimed Life Systems, Inc. | Multiple port fluid control valves |
US20070161970A1 (en) | 2004-04-16 | 2007-07-12 | Medrad, Inc. | Fluid Delivery System, Fluid Path Set, and Pressure Isolation Mechanism with Hemodynamic Pressure Dampening Correction |
US7549977B2 (en) * | 2002-12-20 | 2009-06-23 | Medrad, Inc. | Front load pressure jacket system with syringe holder and light illumination |
US8540698B2 (en) | 2004-04-16 | 2013-09-24 | Medrad, Inc. | Fluid delivery system including a fluid path set and a check valve connector |
US7563249B2 (en) * | 2002-12-20 | 2009-07-21 | Medrad, Inc. | Syringe having an alignment flange, an extending lip and a radial expansion section of reduced wall thickness |
US20080154214A1 (en) | 2006-12-22 | 2008-06-26 | Medrad, Inc. | Flow Based Pressure Isolation and Fluid Delivery System Including Flow Based Pressure Isolation |
BR0214778B1 (en) * | 2001-12-07 | 2013-01-22 | Fluid valve. | |
US6931950B2 (en) * | 2001-12-13 | 2005-08-23 | Xerox Corporation | System and processes for particulate analysis |
WO2003053494A2 (en) * | 2001-12-20 | 2003-07-03 | Medrad, Inc. | Creation and agitation of multi-component fluids in injection systems |
WO2004069153A2 (en) * | 2003-01-27 | 2004-08-19 | Medrad, Inc. | Apparatus, system and method for generating bubbles on demand |
US6968223B2 (en) * | 2002-02-01 | 2005-11-22 | Ge Medical Systems Global Technology Company, Llc | System and method for wireless voice control of an interventional or diagnostic medical device |
US7497827B2 (en) | 2004-07-13 | 2009-03-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US6880808B2 (en) | 2002-05-03 | 2005-04-19 | Acist Medical Systems, Inc. | Gamma-stable high pressure stopcock |
US7457804B2 (en) * | 2002-05-10 | 2008-11-25 | Medrad, Inc. | System and method for automated benchmarking for the recognition of best medical practices and products and for establishing standards for medical procedures |
US20040068230A1 (en) | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US7278983B2 (en) | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US7715902B2 (en) | 2002-09-12 | 2010-05-11 | Brainlab Ag | Determining distribution for planning an infusion |
ATE343142T1 (en) | 2002-09-12 | 2006-11-15 | Brainlab Ag | DISTRIBUTION DETERMINATION FOR INFUSION PLANNING |
US9956377B2 (en) | 2002-09-20 | 2018-05-01 | Angiodynamics, Inc. | Method and apparatus for intra-aortic substance delivery to a branch vessel |
JP4620929B2 (en) * | 2002-09-26 | 2011-01-26 | 株式会社根本杏林堂 | Chemical injection device |
US7801583B2 (en) * | 2002-12-10 | 2010-09-21 | Neorad As | Extravasation detector |
US20080132797A1 (en) * | 2002-12-10 | 2008-06-05 | Knut Brabrand | Monitoring infusion of a substance |
US7361156B2 (en) * | 2002-12-20 | 2008-04-22 | Medrad, Inc. | Pressure jacket system with pivotal locking members |
JP4731795B2 (en) * | 2003-02-18 | 2011-07-27 | 株式会社根本杏林堂 | Chemical injection device |
CA2433205A1 (en) * | 2003-03-18 | 2004-09-18 | James Alexander Keenan | Drug delivery, bodily fluid drainage, and biopsy device with enhanced ultrasonic visibility |
JP2006522658A (en) * | 2003-04-08 | 2006-10-05 | メドラッド インコーポレーテッド | Fluid transport system, fluid transport device, and method for transporting hazardous fluid |
US8249813B2 (en) | 2003-05-22 | 2012-08-21 | Brainlab Ag | System and process for metabolic guidance of introduced cellular material |
DE10325106A1 (en) * | 2003-06-03 | 2004-12-30 | Disetronic Licensing Ag | Device and method for recognizing a user of a medical device |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US7632245B1 (en) * | 2003-08-18 | 2009-12-15 | Medrad, Inc. | Devices, systems and methods for delivery of a fluid into a patient during a magnetic resonance procedure |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7776006B2 (en) * | 2003-11-05 | 2010-08-17 | Baxter International Inc. | Medical fluid pumping system having real time volume determination |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8615282B2 (en) | 2004-07-13 | 2013-12-24 | Dexcom, Inc. | Analyte sensor |
US7666169B2 (en) | 2003-11-25 | 2010-02-23 | Medrad, Inc. | Syringe and syringe plungers for use with medical injectors |
USD1031029S1 (en) | 2003-11-25 | 2024-06-11 | Bayer Healthcare Llc | Syringe plunger |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8774886B2 (en) | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
US8425416B2 (en) | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7968851B2 (en) | 2004-01-13 | 2011-06-28 | Spectrum Dynamics Llc | Dynamic spect camera |
US8586932B2 (en) | 2004-11-09 | 2013-11-19 | Spectrum Dynamics Llc | System and method for radioactive emission measurement |
US8571881B2 (en) | 2004-11-09 | 2013-10-29 | Spectrum Dynamics, Llc | Radiopharmaceutical dispensing, administration, and imaging |
WO2006051531A2 (en) | 2004-11-09 | 2006-05-18 | Spectrum Dynamics Llc | Radioimaging |
US9470801B2 (en) | 2004-01-13 | 2016-10-18 | Spectrum Dynamics Llc | Gating with anatomically varying durations |
WO2008010227A2 (en) | 2006-07-19 | 2008-01-24 | Spectrum Dynamics Llc | Imaging protocols |
US7176466B2 (en) | 2004-01-13 | 2007-02-13 | Spectrum Dynamics Llc | Multi-dimensional image reconstruction |
US7848543B2 (en) | 2004-02-05 | 2010-12-07 | Brainlab Ag | Method and system for prediction and management of material and information transport in an organism |
CN1968653B (en) * | 2004-02-11 | 2011-08-24 | 阿西斯特医疗系统公司 | Method system and apparatus for operating a medical injector and diagnostic imaging device |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
WO2009048462A1 (en) | 2007-10-09 | 2009-04-16 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US7734331B2 (en) * | 2004-03-02 | 2010-06-08 | General Electric Company | Systems, methods and apparatus for preparation, delivery and monitoring of radioisotopes in positron emission tomography |
WO2005102412A2 (en) * | 2004-04-08 | 2005-11-03 | Medrad, Inc. | Control device for a fluid delivery system |
US7556619B2 (en) | 2004-04-16 | 2009-07-07 | Medrad, Inc. | Fluid delivery system having a fluid level sensor and a fluid control device for isolating a patient from a pump device |
EP1765173B1 (en) * | 2004-04-22 | 2016-04-13 | Acist Medical Systems, Inc. | Interface device and protocol |
US8518021B2 (en) * | 2004-05-27 | 2013-08-27 | Baxter International Inc. | Apparatus and method for therapeutic delivery of medication |
JP4795694B2 (en) * | 2004-06-11 | 2011-10-19 | 株式会社東芝 | X-ray CT apparatus and myocardial perfusion image generation system |
EP1769811A1 (en) * | 2004-06-21 | 2007-04-04 | Nemoto Kyorindo Co., Ltd. | Medicinal liquid injection system |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
EP1782853A4 (en) * | 2004-07-14 | 2009-09-16 | Nemoto Kyorindo Co Ltd | Medical liquid injection system |
US20060025667A1 (en) * | 2004-07-29 | 2006-02-02 | Edward Ashton | Method for tumor perfusion assessment in clinical trials using dynamic contrast enhanced MRI |
US20060079842A1 (en) * | 2004-10-13 | 2006-04-13 | Liebel-Flarsheim Company | Powerhead control in a power injection system |
US7507221B2 (en) * | 2004-10-13 | 2009-03-24 | Mallinckrodt Inc. | Powerhead of a power injection system |
US9907485B2 (en) | 2004-10-15 | 2018-03-06 | Brainlab Ag | Targeted immunization and plaque destruction against Alzheimer's disease |
US9924888B2 (en) | 2004-10-15 | 2018-03-27 | Brainlab Ag | Targeted infusion of agents against parkinson's disease |
US9901413B2 (en) | 2004-10-15 | 2018-02-27 | Brainlab Ag | Targeted infusion of agents for treatment of ALS |
US8000773B2 (en) | 2004-11-09 | 2011-08-16 | Spectrum Dynamics Llc | Radioimaging |
US8615405B2 (en) | 2004-11-09 | 2013-12-24 | Biosensors International Group, Ltd. | Imaging system customization using data from radiopharmaceutical-associated data carrier |
US9316743B2 (en) | 2004-11-09 | 2016-04-19 | Biosensors International Group, Ltd. | System and method for radioactive emission measurement |
US9943274B2 (en) | 2004-11-09 | 2018-04-17 | Spectrum Dynamics Medical Limited | Radioimaging using low dose isotope |
CN102512186B (en) * | 2004-11-16 | 2015-07-15 | 拜耳医疗保健公司 | Modeling of pharmaceutical propagation and response of patients to medication injection |
DE102005006657A1 (en) * | 2005-02-14 | 2006-08-31 | Siemens Ag | Method of predicting the flow of a contrast medium in a living body especially of a patient using a summation equation |
US20060211989A1 (en) * | 2005-03-04 | 2006-09-21 | Rhinehart Edward J | Fluid delivery systems, devices and methods for delivery of fluids |
US7853309B2 (en) * | 2005-03-10 | 2010-12-14 | Toshiba Medical Systems Corporation | X-ray CT apparatus and myocardial perfusion image generating system |
US9011377B2 (en) | 2008-11-05 | 2015-04-21 | Bayer Medical Care Inc. | Fluid mixing control device for a multi-fluid delivery system |
US7766883B2 (en) * | 2007-10-30 | 2010-08-03 | Medrad, Inc. | System and method for proportional mixing and continuous delivery of fluids |
US9433730B2 (en) | 2013-03-14 | 2016-09-06 | Bayer Healthcare Llc | Fluid mixing control device for a multi-fluid delivery system |
JP4901243B2 (en) * | 2005-03-30 | 2012-03-21 | 株式会社東芝 | Contrast medium injection management apparatus, diagnostic imaging apparatus, and contrast medium injection apparatus |
DE602006014838D1 (en) * | 2005-04-06 | 2010-07-22 | Mallinckrodt Inc | A system for managing information regarding a syringe and a medical fluid |
CN101217988A (en) * | 2005-04-11 | 2008-07-09 | 株式会社根本杏林堂 | Medical liquid injection system |
WO2006121972A2 (en) * | 2005-05-06 | 2006-11-16 | Stereoraxis, Inc. | Preoperative and intra-operative imaging-based procedure workflow with complexity scoring |
CN101277733B (en) * | 2005-06-21 | 2012-07-11 | 梅德拉股份有限公司 | Medical fluid injection and inflation system |
US8837793B2 (en) | 2005-07-19 | 2014-09-16 | Biosensors International Group, Ltd. | Reconstruction stabilizer and active vision |
US8644910B2 (en) | 2005-07-19 | 2014-02-04 | Biosensors International Group, Ltd. | Imaging protocols |
SE0501889L (en) * | 2005-08-25 | 2007-02-26 | Millicore Ab | Kärlresistansmätare |
DE102005041626A1 (en) * | 2005-09-01 | 2007-03-15 | Siemens Ag | Method and system for generating tomographic images of a patient using contrast agent injections |
DE102005045600B4 (en) * | 2005-09-23 | 2008-01-17 | Siemens Ag | An injector and method for assisting imaging on a patient |
US20090222671A1 (en) | 2005-10-25 | 2009-09-03 | Burbank Jeffrey H | Safety features for medical devices requiring assistance and supervision |
KR101458416B1 (en) * | 2005-11-21 | 2014-11-07 | 어시스트 메디칼 시스템즈, 인크. | Medical fluid injection system |
US8852167B2 (en) | 2005-12-01 | 2014-10-07 | Bayer Medical Care Inc. | Medical connector |
US20070129630A1 (en) * | 2005-12-07 | 2007-06-07 | Shimko Daniel A | Imaging method, device and system |
US20070135706A1 (en) * | 2005-12-13 | 2007-06-14 | Shimko Daniel A | Debridement method, device and kit |
WO2007076463A2 (en) * | 2005-12-27 | 2007-07-05 | Acist Medical Systems, Inc. | Balloon inflation device |
DE102006002896A1 (en) * | 2006-01-20 | 2007-08-09 | Siemens Ag | Imaging apparatus and method for operating an imaging device |
US11364335B2 (en) | 2006-02-09 | 2022-06-21 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
CA3213521A1 (en) | 2006-02-09 | 2007-08-16 | Deka Products Limited Partnership | Peripheral systems |
US11478623B2 (en) | 2006-02-09 | 2022-10-25 | Deka Products Limited Partnership | Infusion pump assembly |
US11497846B2 (en) | 2006-02-09 | 2022-11-15 | Deka Products Limited Partnership | Patch-sized fluid delivery systems and methods |
US11027058B2 (en) | 2006-02-09 | 2021-06-08 | Deka Products Limited Partnership | Infusion pump assembly |
US8805700B2 (en) * | 2006-03-14 | 2014-08-12 | Nemoto Kyorindo Co., Ltd. | Medical image system |
US8926569B2 (en) | 2006-03-15 | 2015-01-06 | Bayer Medical Care Inc. | Plunger covers and plungers for use in syringes and methods of fabricating plunger covers and plungers for use in syringes |
US20080033368A1 (en) * | 2006-04-04 | 2008-02-07 | Mallinckrodt Inc. | Systems and methods for managing information relating to medical fluids and containers therefor |
US8862207B2 (en) * | 2006-04-05 | 2014-10-14 | Resource One Inc | Fluoroscopic imaging system |
JP5135211B2 (en) * | 2006-04-05 | 2013-02-06 | 株式会社リソースワン | Perspective imaging system and data control apparatus |
US7618397B2 (en) * | 2006-04-12 | 2009-11-17 | Medrad, Inc. | Fluid delivery system with pump cassette |
US8112292B2 (en) | 2006-04-21 | 2012-02-07 | Medtronic Navigation, Inc. | Method and apparatus for optimizing a therapy |
US8894974B2 (en) | 2006-05-11 | 2014-11-25 | Spectrum Dynamics Llc | Radiopharmaceuticals for diagnosis and therapy |
US9233176B2 (en) * | 2006-06-06 | 2016-01-12 | Bayer Healthcare Llc | Systems and method of delivering fluids to a patient of varying concentration |
EP1867356A1 (en) * | 2006-06-16 | 2007-12-19 | Swiss Medical Care | System for the injection of contrast agents |
US7601966B2 (en) | 2006-06-28 | 2009-10-13 | Spectrum Dynamics Llc | Imaging techniques for reducing blind spots |
CN101534713A (en) * | 2006-07-17 | 2009-09-16 | 梅德拉股份有限公司 | Integrated medical imaging systems |
US8660635B2 (en) | 2006-09-29 | 2014-02-25 | Medtronic, Inc. | Method and apparatus for optimizing a computer assisted surgical procedure |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
US8447376B2 (en) | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8298142B2 (en) | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
US8610075B2 (en) | 2006-11-13 | 2013-12-17 | Biosensors International Group Ltd. | Radioimaging applications of and novel formulations of teboroxime |
US7974682B2 (en) | 2006-11-22 | 2011-07-05 | Marcela Gonzalez Molezzi | System and method to adaptively control contrast-enhanced diagnostic imaging procedure |
WO2008075362A2 (en) | 2006-12-20 | 2008-06-26 | Spectrum Dynamics Llc | A method, a system, and an apparatus for using and processing multidimensional data |
HUE040477T2 (en) | 2006-12-29 | 2019-03-28 | Bayer Healthcare Llc | Patient-based parameter generation systems for medical injection procedures |
US20100030073A1 (en) * | 2006-12-29 | 2010-02-04 | Medrad, Inc. | Modeling of pharmaceutical propagation |
US8382704B2 (en) * | 2006-12-29 | 2013-02-26 | Medrad, Inc. | Systems and methods of delivering a dilated slurry to a patient |
ES2677024T3 (en) | 2007-01-01 | 2018-07-27 | Bayer Healthcare Llc | Systems for generation, preparation, transport and administration of integrated radiopharmaceutical products |
US9056164B2 (en) | 2007-01-01 | 2015-06-16 | Bayer Medical Care Inc. | Radiopharmaceutical administration methods, fluid delivery systems and components thereof |
US20080166292A1 (en) * | 2007-01-01 | 2008-07-10 | Medrad, Inc. | Pharmaceutical Dosing Method |
WO2008094511A2 (en) * | 2007-01-29 | 2008-08-07 | Bruce Reiner | Quality assurance scorecard for diagnostic medical agent administration |
USD942005S1 (en) | 2007-03-14 | 2022-01-25 | Bayer Healthcare Llc | Orange syringe plunger cover |
USD847985S1 (en) | 2007-03-14 | 2019-05-07 | Bayer Healthcare Llc | Syringe plunger cover |
USD1002840S1 (en) | 2007-03-14 | 2023-10-24 | Bayer Healthcare Llc | Syringe plunger |
JP2007222656A (en) * | 2007-04-10 | 2007-09-06 | Medrad Inc | Fluid delivery system, pressure isolation mechanism, injector control mechanism, and method of using them |
US20200037874A1 (en) | 2007-05-18 | 2020-02-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
AU2008254328A1 (en) | 2007-05-18 | 2008-11-27 | The Johns Hopkins University | A treatment simulator for brain diseases and method of use thereof |
JP5249210B2 (en) * | 2007-05-30 | 2013-07-31 | 株式会社根本杏林堂 | Chemical injection device, fluoroscopic imaging system, computer program |
DE102007025399A1 (en) * | 2007-05-31 | 2008-12-11 | Siemens Ag | Medical technical diagnostic system |
US20090069830A1 (en) * | 2007-06-07 | 2009-03-12 | Piezo Resonance Innovations, Inc. | Eye surgical tool |
US20080306434A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US8043229B2 (en) * | 2007-06-29 | 2011-10-25 | Actuated Medical, Inc. | Medical tool for reduced penetration force |
US8328738B2 (en) | 2007-06-29 | 2012-12-11 | Actuated Medical, Inc. | Medical tool for reduced penetration force with feedback means |
US10219832B2 (en) | 2007-06-29 | 2019-03-05 | Actuated Medical, Inc. | Device and method for less forceful tissue puncture |
US9987468B2 (en) | 2007-06-29 | 2018-06-05 | Actuated Medical, Inc. | Reduced force device for intravascular access and guidewire placement |
CN101742967B (en) | 2007-07-17 | 2014-06-11 | 梅德拉股份有限公司 | Devices, systems and methods for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery |
US8012120B2 (en) * | 2007-09-13 | 2011-09-06 | Avant Medical Corp. | Device and method for the automatic initiation of an injection |
CN101820934B (en) * | 2007-10-10 | 2012-09-05 | 奥林巴斯株式会社 | Medicinal solution dispenser |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8521253B2 (en) | 2007-10-29 | 2013-08-27 | Spectrum Dynamics Llc | Prostate imaging |
ES2426456T3 (en) * | 2007-11-19 | 2013-10-23 | Mallinckrodt Llc | Power injector that has permeability checking with pressure monitoring |
US8500677B2 (en) * | 2007-11-20 | 2013-08-06 | Mallinckrodt Llc | Power injector with flow rate assessment |
US9839395B2 (en) | 2007-12-17 | 2017-12-12 | Dexcom, Inc. | Systems and methods for processing sensor data |
EP2244765B1 (en) | 2007-12-31 | 2019-08-14 | DEKA Products Limited Partnership | Infusion pump assembly |
US10080704B2 (en) | 2007-12-31 | 2018-09-25 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US9456955B2 (en) | 2007-12-31 | 2016-10-04 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US8900188B2 (en) | 2007-12-31 | 2014-12-02 | Deka Products Limited Partnership | Split ring resonator antenna adapted for use in wirelessly controlled medical device |
BR122020005551B1 (en) | 2007-12-31 | 2021-08-10 | Deka Products Limited Partnership | INFUSION PUMP SET |
US10188787B2 (en) | 2007-12-31 | 2019-01-29 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US8881774B2 (en) | 2007-12-31 | 2014-11-11 | Deka Research & Development Corp. | Apparatus, system and method for fluid delivery |
EP2252196A4 (en) | 2008-02-21 | 2013-05-15 | Dexcom Inc | Systems and methods for processing, transmitting and displaying sensor data |
US8608484B2 (en) | 2008-03-04 | 2013-12-17 | Medrad, Inc. | Dynamic anthropomorphic cardiovascular phantom |
US20090234231A1 (en) * | 2008-03-13 | 2009-09-17 | Knight Jon M | Imaging Catheter With Integrated Contrast Agent Injector |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
CA2630561C (en) * | 2008-04-30 | 2014-07-08 | Medical Systems | Contrast media injector kit |
US7873404B1 (en) | 2008-05-29 | 2011-01-18 | Seth Caplan | Method for performing angioplasty and angiography with a single catheter |
CN104587552B (en) | 2008-06-06 | 2017-11-14 | 拜耳医药保健有限公司 | For delivering fluid injection pill and the apparatus and method for handling harmful fluids to patient |
US8317674B2 (en) | 2008-06-11 | 2012-11-27 | Bracco Diagnostics Inc. | Shielding assemblies for infusion systems |
US9597053B2 (en) * | 2008-06-11 | 2017-03-21 | Bracco Diagnostics Inc. | Infusion systems including computer-facilitated maintenance and/or operation and methods of use |
US8708352B2 (en) * | 2008-06-11 | 2014-04-29 | Bracco Diagnostics Inc. | Cabinet structure configurations for infusion systems |
US7862534B2 (en) * | 2008-06-11 | 2011-01-04 | Bracco Diagnostics Inc. | Infusion circuit subassemblies |
AU2009257432B2 (en) | 2008-06-11 | 2014-11-13 | Bracco Diagnostics Inc. | Infusion systems including computer-facilitated maintenance and/or operation |
US8315449B2 (en) | 2008-06-24 | 2012-11-20 | Medrad, Inc. | Identification of regions of interest and extraction of time value curves in imaging procedures |
EP2361105B1 (en) | 2008-09-15 | 2021-06-02 | DEKA Products Limited Partnership | Systems and methods for fluid delivery |
US8165658B2 (en) * | 2008-09-26 | 2012-04-24 | Medtronic, Inc. | Method and apparatus for positioning a guide relative to a base |
US8708376B2 (en) | 2008-10-10 | 2014-04-29 | Deka Products Limited Partnership | Medium connector |
US8262616B2 (en) | 2008-10-10 | 2012-09-11 | Deka Products Limited Partnership | Infusion pump assembly |
US9180245B2 (en) | 2008-10-10 | 2015-11-10 | Deka Products Limited Partnership | System and method for administering an infusible fluid |
US8016789B2 (en) | 2008-10-10 | 2011-09-13 | Deka Products Limited Partnership | Pump assembly with a removable cover assembly |
US8066672B2 (en) | 2008-10-10 | 2011-11-29 | Deka Products Limited Partnership | Infusion pump assembly with a backup power supply |
US8223028B2 (en) | 2008-10-10 | 2012-07-17 | Deka Products Limited Partnership | Occlusion detection system and method |
US8267892B2 (en) | 2008-10-10 | 2012-09-18 | Deka Products Limited Partnership | Multi-language / multi-processor infusion pump assembly |
US8216181B2 (en) * | 2008-11-19 | 2012-07-10 | Bracco Diagnostics, Inc. | Apparatus and methods for support of a membrane filter in a medical infusion system |
DE102008060719B4 (en) * | 2008-12-05 | 2018-09-20 | Siemens Healthcare Gmbh | Method for controlling the recording operation of a magnetic resonance device during the recording of magnetic resonance data of a patient and associated magnetic resonance device |
DE102009007047B4 (en) * | 2009-02-02 | 2018-09-20 | Siemens Healthcare Gmbh | Method for controlling an injector for contrast media in a magnetic resonance system and magnetic resonance system |
WO2010101184A1 (en) * | 2009-03-04 | 2010-09-10 | 株式会社根本杏林堂 | Chemical injection device and x-ray ct system |
CN105919618A (en) | 2009-04-17 | 2016-09-07 | 皇家飞利浦电子股份有限公司 | Agent-based imaging |
CA2768011C (en) | 2009-07-15 | 2018-07-24 | Deka Products Limited Partnership | Apparatus, systems and methods for an infusion pump assembly |
DK2962770T3 (en) | 2009-07-24 | 2017-07-03 | Bayer Healthcare Llc | MEDICAL MULTI-FLUID INJECTION SYSTEM |
US8338788B2 (en) | 2009-07-29 | 2012-12-25 | Spectrum Dynamics Llc | Method and system of optimized volumetric imaging |
US20110097229A1 (en) * | 2009-10-09 | 2011-04-28 | Cauley Iii Thomas Henry | Feedback Controlled Syringe Pump |
EP3415185A3 (en) | 2009-12-03 | 2019-02-27 | Jean-Pierre Peters | Fluid interconnection set with particle filter |
DE102009057930A1 (en) * | 2009-12-11 | 2011-06-16 | Siemens Aktiengesellschaft | Method for regulating a vascular intervention and device for regulating vascular intervention |
WO2011091265A1 (en) | 2010-01-22 | 2011-07-28 | Deka Products Limited Partnership | Method and system for shape-memory alloy wire control |
WO2011125987A1 (en) * | 2010-04-06 | 2011-10-13 | 株式会社根本杏林堂 | Drug solution injection device |
CN102939120B (en) | 2010-06-04 | 2016-12-07 | 拜耳医药保健有限责任公司 | The system and method that multiple dose radiopharmaceutical in radiopharmaceutical syringe uses for planning and monitoring |
EP2460546A1 (en) * | 2010-12-01 | 2012-06-06 | F. Hoffmann-La Roche AG | Ambulatory infusion device and method for acoustically signaling numerical values |
US20120190966A1 (en) * | 2011-01-24 | 2012-07-26 | Shawn Schaerer | MR Compatible Fluorescence Viewing Device for use in the Bore of an MR Magnet |
CN103561800B (en) | 2011-03-18 | 2017-02-15 | 利贝尔-弗拉施姆有限公司 | Apparatus and method to determine contrast media injection parameters to control signal intensity during magnetic resonance angiography |
JP6141827B2 (en) | 2011-04-15 | 2017-06-07 | デックスコム・インコーポレーテッド | Method of operating a system for measuring an analyte and sensor system configured to implement the method |
WO2012167257A1 (en) | 2011-06-03 | 2012-12-06 | Medrad, Inc. | System and method for rapid quantitative dynamic molecular imaging scans |
US9314584B1 (en) * | 2011-06-27 | 2016-04-19 | Bayer Healthcare Llc | Method and apparatus for fractional flow reserve measurements |
EP2758096A4 (en) | 2011-09-21 | 2015-07-01 | Bayer Medical Care Inc | Continuous multi-fluid delivery system and method |
RU2623490C2 (en) | 2011-10-19 | 2017-06-26 | БАЙЕР ХелсКер ЛЛСи | Sterile maintaining medical connector unit and method |
DE102011085618A1 (en) * | 2011-11-02 | 2013-05-02 | Siemens Aktiengesellschaft | Control unit and medical examination device with a control unit |
WO2013134519A2 (en) | 2012-03-07 | 2013-09-12 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US9889288B2 (en) | 2012-06-07 | 2018-02-13 | Bayer Healthcare Llc | Tubing connectors |
US9125976B2 (en) | 2012-06-07 | 2015-09-08 | Bayer Medical Care Inc. | Shield adapters |
US9393441B2 (en) | 2012-06-07 | 2016-07-19 | Bayer Healthcare Llc | Radiopharmaceutical delivery and tube management system |
FR2991880B1 (en) * | 2012-06-13 | 2019-11-22 | Medex | CONTROLLER FOR THE INJECTION DEVICE |
FR2991881B1 (en) | 2012-06-13 | 2014-09-05 | Medex Sa | DEVICE FOR INJECTING A LIQUID PRODUCT COMPRISING TWO MOBILE HALF-SHELLS IN ROTATION IN RELATION TO EACH OTHER |
US10022497B2 (en) | 2012-08-28 | 2018-07-17 | Osprey Medical, Inc. | Reservoir for collection and reuse of diverted medium |
US9320846B2 (en) | 2012-08-28 | 2016-04-26 | Osprey Medical, Inc. | Devices and methods for modulating medium delivery |
US11116892B2 (en) | 2012-08-28 | 2021-09-14 | Osprey Medical, Inc. | Medium injection diversion and measurement |
US11219719B2 (en) | 2012-08-28 | 2022-01-11 | Osprey Medical, Inc. | Volume monitoring systems |
US10010673B2 (en) | 2012-08-28 | 2018-07-03 | Osprey Medical, Inc. | Adjustable medium diverter |
US9999718B2 (en) | 2012-08-28 | 2018-06-19 | Osprey Medical, Inc. | Volume monitoring device utilizing light-based systems |
US10413677B2 (en) | 2012-08-28 | 2019-09-17 | Osprey Medical, Inc. | Volume monitoring device |
US10279112B2 (en) | 2012-09-24 | 2019-05-07 | Angiodynamics, Inc. | Power injector device and method of use |
US9174003B2 (en) | 2012-09-28 | 2015-11-03 | Bayer Medical Care Inc. | Quick release plunger |
US10820872B2 (en) * | 2012-12-19 | 2020-11-03 | Koninklijke Philips N.V. | X-ray controlled contrast agent injection |
US11369739B2 (en) * | 2013-01-21 | 2022-06-28 | Medline Industries, Lp | Method to provide injection system parameters for injecting fluid into patient |
US9757591B2 (en) | 2013-02-11 | 2017-09-12 | Bayer Healthcare Llc | Methods and systems for monitoring an automated infusion system |
US9555379B2 (en) | 2013-03-13 | 2017-01-31 | Bayer Healthcare Llc | Fluid path set with turbulent mixing chamber, backflow compensator |
US9486573B2 (en) | 2013-03-14 | 2016-11-08 | Bayer Healthcare Llc | Fluid delivery system and method of fluid delivery to a patient |
AU2014277993A1 (en) | 2013-06-14 | 2016-01-21 | Bayer Healthcare, Llc. | Portable fluid delivery system |
CA2914977C (en) | 2013-07-03 | 2021-11-02 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
CN105358115A (en) | 2013-07-17 | 2016-02-24 | 拜耳医疗保健股份有限公司 | Cartridge-based in-bore infuser |
EP3035979A4 (en) * | 2013-08-22 | 2017-05-03 | Intersect Partners, LLC | Method and apparatus for monitoring total delivered dose of contrast media |
US10369276B2 (en) * | 2013-11-25 | 2019-08-06 | Bayer Healthcare Llc | Accurately delivering partial doses of a drug post dilution using an injector |
WO2015081109A1 (en) | 2013-11-26 | 2015-06-04 | Bayer Medical Care Inc. | System and method for medical fluid identification and verification |
NZ722989A (en) | 2014-01-10 | 2018-10-26 | Bayer Healthcare Llc | Single-use disposable set connector |
AU2015229189B2 (en) | 2014-03-13 | 2020-04-09 | Bracco Diagnostics Inc. | Real time nuclear isotope detection |
EP3119453B1 (en) | 2014-03-19 | 2019-02-27 | Bayer Healthcare LLC | System for syringe engagement to an injector |
US10675003B2 (en) * | 2014-07-11 | 2020-06-09 | Acist Medical Systems, Inc. | Intravascular imaging |
GB2533566B (en) * | 2014-12-19 | 2018-02-14 | Gen Electric | Method for contrast medium injection volume estimation based on image analysis |
KR102528289B1 (en) | 2015-01-09 | 2023-05-03 | 바이엘 헬쓰케어 엘엘씨 | Multiple fluid delivery systems with multiple use disposable sets and features thereof |
US10905836B2 (en) | 2015-04-02 | 2021-02-02 | Hill-Rom Services Pte. Ltd. | Manifold for respiratory device |
US10940292B2 (en) | 2015-07-08 | 2021-03-09 | Actuated Medical, Inc. | Reduced force device for intravascular access and guidewire placement |
US11793543B2 (en) | 2015-09-18 | 2023-10-24 | Obvius Robotics, Inc. | Device and method for automated insertion of penetrating member |
US9480797B1 (en) | 2015-10-28 | 2016-11-01 | Bayer Healthcare Llc | System and method for syringe plunger engagement with an injector |
DE102015222853A1 (en) * | 2015-11-19 | 2017-05-24 | Siemens Healthcare Gmbh | Method for automatically determining a contrast agent injection protocol |
EP3423130A1 (en) | 2016-03-03 | 2019-01-09 | Bayer Healthcare LLC | System and method for improved fluid delivery in multi-fluid injector systems |
US11406333B2 (en) * | 2016-05-09 | 2022-08-09 | Canon Medical Systems Corporation | Medical image diagnosis apparatus and management apparatus |
TWI651107B (en) | 2016-06-15 | 2019-02-21 | 拜耳保健公司 | Multi-use disposable system and syringe therefor |
WO2018009498A1 (en) | 2016-07-06 | 2018-01-11 | Bayer Healthcare Llc | Contrast heating system with in-line contrast warmer |
US11752254B2 (en) | 2016-09-20 | 2023-09-12 | Bracco Diagnostics Inc. | Radioisotope delivery system with multiple detectors to detect gamma and beta emissions |
JP7191821B2 (en) | 2016-11-14 | 2022-12-19 | バイエル・ヘルスケア・エルエルシー | Method and system for confirming contents of syringes used for medical fluid delivery |
WO2018098130A1 (en) | 2016-11-22 | 2018-05-31 | Bayer Healthcare Llc | System and method for delivering a fluid with a consistent total volumetric flowrate |
JP7027423B2 (en) | 2016-11-22 | 2022-03-01 | バイエル・ヘルスケア・エルエルシー | Synthetic magnetic resonance imaging with contrast agent and magnetic resonance fingerprinting, as well as determination of contrast injection protocol |
CN115282407B (en) | 2017-01-06 | 2024-07-16 | 拜耳医药保健有限公司 | Syringe plunger with dynamic seal |
US11542936B2 (en) * | 2017-03-24 | 2023-01-03 | Fresenius Kabi Usa, Llc | Fluid flow control and delivery via multiple fluid pumps |
US11566614B2 (en) * | 2017-03-24 | 2023-01-31 | Fresenius Kabi Usa, Llc | Fluid flow control and delivery via multiple fluid pumps |
WO2018218132A1 (en) | 2017-05-26 | 2018-11-29 | Bayer Healthcare Llc | Injector state logic with hemodynamic monitoring |
US11565035B2 (en) | 2017-06-16 | 2023-01-31 | Bayer Healthcare Llc | Systems and methods for split bolus protocol generation |
US11141535B2 (en) | 2017-08-31 | 2021-10-12 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
CA3067625C (en) | 2017-08-31 | 2024-04-30 | Bayer Healthcare Llc | Injector pressure calibration system and method |
WO2019046260A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | Method for dynamic pressure control in a fluid injector system |
US11478581B2 (en) | 2017-08-31 | 2022-10-25 | Bayer Healthcare Llc | Fluid injector system volume compensation system and method |
WO2019046261A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US20190120785A1 (en) | 2017-10-24 | 2019-04-25 | Dexcom, Inc. | Pre-connected analyte sensors |
DK3758777T3 (en) | 2018-02-27 | 2023-02-27 | Bayer Healthcare Llc | INJECTION PISTON ENGAGEMENT MECHANISM |
DE102018107080A1 (en) * | 2018-03-26 | 2019-09-26 | IMAGE Information Systems Europe GmbH | Apparatus and system for generating at least one injection parameter for a contrast agent injector for computed tomography acquisition and methods therewith |
EP3776599B1 (en) | 2018-03-28 | 2023-09-13 | Bracco Diagnostics Inc. | Early detection of radioisotope generator end life |
CA3095939C (en) | 2018-04-06 | 2023-09-26 | Frank Levy | Apparatus and method for producing an enriched medical suspension |
US20190307948A1 (en) * | 2018-04-06 | 2019-10-10 | Frank Levy | Apparatus and method for producing an enriched medical contrast suspension |
US11523972B2 (en) | 2018-04-24 | 2022-12-13 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
EP3797399A1 (en) | 2018-05-23 | 2021-03-31 | ACIST Medical Systems, Inc. | Flow measurement using image data |
CN108992743B (en) * | 2018-08-06 | 2022-01-07 | 广州友沃医疗设备有限公司 | Injection method and device for automatically generating injection plan |
US12002203B2 (en) | 2019-03-12 | 2024-06-04 | Bayer Healthcare Llc | Systems and methods for assessing a likelihood of CTEPH and identifying characteristics indicative thereof |
WO2020210623A1 (en) | 2019-04-12 | 2020-10-15 | Osprey Medical Inc. | Energy-efficient position determining with multiple sensors |
EP4031894B1 (en) | 2019-09-18 | 2023-06-07 | Bayer Aktiengesellschaft | Predicting mri images by prediction model trained by supervised learning |
AU2020349121A1 (en) | 2019-09-18 | 2022-03-31 | Bayer Aktiengesellschaft | System, method, and computer program product for predicting, anticipating, and/or assessing tissue characteristics |
JP2023530475A (en) | 2020-06-18 | 2023-07-18 | バイエル・ヘルスケア・エルエルシー | Systems and methods for syringe plunger engagement with injector |
US11633534B2 (en) | 2020-08-18 | 2023-04-25 | Acist Medical Systems, Inc. | Angiogram injections using electrocardiographic synchronization |
EP4144653A1 (en) * | 2021-09-02 | 2023-03-08 | Steriline S.r.l. | Control method of an electromechanical apparatus for installing a bung element of a pharmaceutical container |
WO2023159229A1 (en) | 2022-02-21 | 2023-08-24 | Bayer Healthcare Llc | System, method and device for delivery of a therapeutic or diagnostic agent |
WO2023239742A1 (en) * | 2022-06-06 | 2023-12-14 | Medtronic Vascular, Inc. | Use of cath lab images for prediction and control of contrast usage |
DE102022207304A1 (en) | 2022-07-18 | 2024-01-18 | Siemens Healthcare Gmbh | Method and system for providing a procedure parameter |
Citations (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3520295A (en) * | 1968-03-06 | 1970-07-14 | Gen Electric | Cardiac r-wave detector with automatic gain control |
US3523523A (en) * | 1966-06-30 | 1970-08-11 | Contraves Ag | Power driven medical injector syringe with electromagnetic coupling means |
US4151845A (en) * | 1977-11-25 | 1979-05-01 | Miles Laboratories, Inc. | Blood glucose control apparatus |
US4263916A (en) * | 1978-03-27 | 1981-04-28 | University Of Southern California | Image averaging for angiography by registration and combination of serial images |
US4280494A (en) * | 1979-06-26 | 1981-07-28 | Cosgrove Robert J Jun | System for automatic feedback-controlled administration of drugs |
US4392847A (en) * | 1979-01-08 | 1983-07-12 | Whitney Douglass G | Injection and monitoring system |
US4392849A (en) * | 1981-07-27 | 1983-07-12 | The Cleveland Clinic Foundation | Infusion pump controller |
US4448200A (en) * | 1978-03-27 | 1984-05-15 | University Of Southern California | System and method for dynamic background subtraction |
US4477923A (en) * | 1982-02-03 | 1984-10-16 | Siemens Aktiengesellschaft | X-ray diagnostic system for angiographic radiographs |
US4504908A (en) * | 1982-03-15 | 1985-03-12 | General Electric Company | Matched filter for X-ray temporal subtraction |
US4542459A (en) * | 1982-11-26 | 1985-09-17 | General Electric Company | Matched filter for x-ray hybrid subtraction |
US4578802A (en) * | 1983-06-27 | 1986-03-25 | Kabushiki Kaisha Toshiba | X-ray diagnostic apparatus for allowing stereoscopic visualization on X-ray images of an object under examination |
US4611340A (en) * | 1983-05-20 | 1986-09-09 | Kabushiki Kaisha Toshiba | Apparatus for examining a biological object by using radiation |
US4612572A (en) * | 1983-03-31 | 1986-09-16 | Tokyo Shibaura Denki Kabushiki Kaisha | X-ray television diagnostic apparatus |
US4672651A (en) * | 1985-03-28 | 1987-06-09 | Hitachi Medical Corporation | Method of and apparatus for reconstructing shape of interested part of object through irradiation with X-rays |
US4676776A (en) * | 1985-01-18 | 1987-06-30 | Intelligent Medicine, Inc. | Device and method for effecting application of a therapeutic agent |
US4689670A (en) * | 1984-01-19 | 1987-08-25 | Kabushiki Kaisha Toshiba | Method and apparatus for measuring a biological function of a subject |
US4723261A (en) * | 1983-12-22 | 1988-02-02 | U.S. Philips Corporation | X-ray examination apparatus incorporating image subtraction |
US4804454A (en) * | 1986-03-19 | 1989-02-14 | Honda Giken Kagyo Kabushiki Kaisha | Oxygen concentration sensing apparatus |
US4903705A (en) * | 1984-11-09 | 1990-02-27 | Hitachi Medical Corporation | Digital radiography apparatus |
US4913154A (en) * | 1987-11-19 | 1990-04-03 | Siemens Aktiengesellschaft | Medical examination installation with improved image contrast |
US4943987A (en) * | 1987-08-07 | 1990-07-24 | Kabushiki Kaisha Toshiba | Method and system for displaying X-ray images of blood-vessel structure parts of subject |
US4947412A (en) * | 1988-10-20 | 1990-08-07 | Picker International, Inc. | X-ray detector for CT scanners |
US4965726A (en) * | 1988-10-20 | 1990-10-23 | Picker International, Inc. | CT scanner with segmented detector array |
US4995064A (en) * | 1990-01-29 | 1991-02-19 | Siemens Medical Systems, Inc. | Continuously sweeping multiple-pass image acquisition system for peripheral angiography |
US5010473A (en) * | 1989-08-31 | 1991-04-23 | Duke University | Method and apparatus for model-based control of an open-loop process |
US5018173A (en) * | 1988-10-18 | 1991-05-21 | Kabushiki Kaisha Toshiba | Diagnosis apparatus using X-ray CT device |
US5034987A (en) * | 1988-12-09 | 1991-07-23 | Nippon Identograph Co., Ltd. | Continuous photographing and observing of a three-dimensional image |
US5054044A (en) * | 1986-05-06 | 1991-10-01 | Thomson-Cgr | Radiology installation with a communications network |
US5111492A (en) * | 1990-07-06 | 1992-05-05 | General Electric Cgr S.A. | X-ray diagnosis system for angiographic examination with device for the automatic tracking of a contrast medium |
US5123056A (en) * | 1990-02-02 | 1992-06-16 | Siemens Medical Systems, Inc. | Whole-leg x-ray image processing and display techniques |
US5125018A (en) * | 1990-06-29 | 1992-06-23 | Kabushiki Kaisha Toshiba | X-ray diagnostic apparatus |
US5150292A (en) * | 1989-10-27 | 1992-09-22 | Arch Development Corporation | Method and system for determination of instantaneous and average blood flow rates from digital angiograms |
US5166961A (en) * | 1988-10-20 | 1992-11-24 | Picker International, Inc. | CT scanner having multiple detector widths |
US5190744A (en) * | 1990-03-09 | 1993-03-02 | Salutar | Methods for detecting blood perfusion variations by magnetic resonance imaging |
US5215095A (en) * | 1990-08-10 | 1993-06-01 | University Technologies International | Optical imaging system for neurosurgery |
US5228070A (en) * | 1988-10-20 | 1993-07-13 | Picker International, Inc. | Constant image quality CT scanner with variable radiation flux density |
US5249122A (en) * | 1990-03-15 | 1993-09-28 | Mount Sinai School Of Medicine Of The City University Of New York | Method and apparatus for forming images using orthogonal polynomials for temporal deconvolution |
US5249579A (en) * | 1990-03-09 | 1993-10-05 | E-Z-Em, Inc. | Contrast media injector |
US5262946A (en) * | 1988-10-20 | 1993-11-16 | Picker International, Inc. | Dynamic volume scanning for CT scanners |
US5276614A (en) * | 1989-11-17 | 1994-01-04 | Picker International, Inc. | Dynamic bandwidth reconstruction |
US5286252A (en) * | 1988-02-19 | 1994-02-15 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
US5287273A (en) * | 1990-03-15 | 1994-02-15 | Mount Sinai School Of Medicine | Functional organ images |
US5301672A (en) * | 1991-12-09 | 1994-04-12 | Siemens Aktiengesellschaft | Radiological diagnostics system employing a contrast agent |
US5311568A (en) * | 1992-05-01 | 1994-05-10 | Picker International, Inc. | Optical alignment means utilizing inverse projection of a test pattern/target |
US5388139A (en) * | 1989-12-07 | 1995-02-07 | Electromed International | High-voltage power supply and regulator circuit for an X-ray tube with closed-loop feedback for controlling X-ray exposure |
US5450847A (en) * | 1991-04-22 | 1995-09-19 | Schering Aktiengesellschaft | Process for making doses formulation of contrast media from concentrate |
US5840026A (en) * | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
Family Cites Families (182)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1220394B (en) * | 1964-09-12 | 1966-07-07 | Glanzstoff Koeln Ges Mit Besch | Device for the continuous mixing and homogenizing of liquids of different viscosities |
US3623474A (en) | 1966-07-25 | 1971-11-30 | Medrad Inc | Angiographic injection equipment |
US3701345A (en) * | 1970-09-29 | 1972-10-31 | Medrad Inc | Angiographic injector equipment |
US3793600A (en) * | 1971-03-16 | 1974-02-19 | Strategic Automated Systems In | Record medium with validating and cancelling feature and method |
US4001549A (en) * | 1971-06-10 | 1977-01-04 | Corwin Edward J | Marking document and template assembly and method of making the assembly |
US3927955A (en) | 1971-08-23 | 1975-12-23 | East West Medical Products Inc | Medical cassette pump |
US3755655A (en) * | 1971-10-26 | 1973-08-28 | Tac Ind Inc | Machine processed data card |
US3839708A (en) | 1972-06-28 | 1974-10-01 | Searle Medidata Inc | Input-output terminal for hospital information system |
US3812843A (en) * | 1973-03-12 | 1974-05-28 | Lear Siegler Inc | Method and apparatus for injecting contrast media into the vascular system |
JPS5011296A (en) * | 1973-05-31 | 1975-02-05 | ||
US3895220A (en) * | 1973-09-07 | 1975-07-15 | Docutronix Inc | Selectively encodable envelope insert and related apparatus |
US3898983A (en) * | 1973-10-03 | 1975-08-12 | James O Elam | Device and method for detecting the degree of muscle relaxation of a medical patient |
US3968195A (en) * | 1974-06-17 | 1976-07-06 | Marilyn Bishop | Method for making sterile connections |
US3888239A (en) | 1974-06-21 | 1975-06-10 | Morton K Rubinstein | Fluid injection system |
US4038981A (en) * | 1974-07-26 | 1977-08-02 | Burron Medical Products, Inc. | Electronically controlled intravenous infusion set |
US3941126A (en) * | 1974-08-08 | 1976-03-02 | Dietrich Joseph W | Apparatus for long term intravenous administration of diluted incompatible multiple medications |
US3995381A (en) * | 1975-06-27 | 1976-12-07 | Ken Max Manfred | Low visibility answer sheet and method of testing |
JPS5226193A (en) | 1975-08-22 | 1977-02-26 | Houseikai | Remote control barium injector |
US4284073A (en) | 1977-10-11 | 1981-08-18 | Krause Horst E | Method and apparatus for pumping blood within a vessel |
US4191183A (en) | 1977-10-31 | 1980-03-04 | Barry Mendelson | Mixing chamber for use in plural medical liquid intravenous administration set |
US4187057A (en) * | 1978-01-11 | 1980-02-05 | Stewart-Naumann Laboratories, Inc. | Peristaltic infusion pump and disposable cassette for use therewith |
US4262824A (en) * | 1978-02-17 | 1981-04-21 | Baxter Travenol Laboratories, Inc. | Low-current E-frame electronic magnet with a permanent magnet armature for an I. V. valving controller |
US4207871A (en) * | 1978-06-07 | 1980-06-17 | Imed Corporation | System for controlling the flow of intravenous fluids to a patient |
US4199000A (en) * | 1978-07-19 | 1980-04-22 | Edstrom William E | Cross-contamination isolator |
US4223675A (en) * | 1978-07-24 | 1980-09-23 | Baxter Travenol Laboratories, Inc. | Solution containers such as blood bags and system for preparing same |
JPS56500240A (en) * | 1979-02-28 | 1981-03-05 | ||
US4319568A (en) * | 1979-10-29 | 1982-03-16 | Vickers Limited | Liquid dispensing apparatus |
CA1171030A (en) * | 1979-11-05 | 1984-07-17 | David Bellamy | Fluid transfer assembly |
JPS5675131A (en) | 1979-11-22 | 1981-06-22 | Olympus Optical Co | Endoscope apparatus |
US4341153A (en) | 1980-01-08 | 1982-07-27 | Truswal Systems Corp. | Splicing and truss assembly apparatus and methods |
FR2493708A1 (en) * | 1980-11-07 | 1982-05-14 | Mecaserto | Appts. for preparing solns. for physiological injection - to automate mixing and transfer from remote control |
US4340153A (en) * | 1980-11-28 | 1982-07-20 | Spivey David L | Method and apparatus for medication dispensing |
US4396385A (en) * | 1980-12-05 | 1983-08-02 | Baxter Travenol Laboratories, Inc. | Flow metering apparatus for a fluid infusion system |
US4409966A (en) * | 1981-05-29 | 1983-10-18 | Lambrecht Richard M | Method and apparatus for injecting a substance into the bloodstream of a subject |
US4447230A (en) * | 1981-08-05 | 1984-05-08 | Quest Medical, Inc. | Intravenous administration set assembly |
US4444198A (en) | 1981-12-21 | 1984-04-24 | Petre John H | Circulatory monitoring system and method |
JPS58152542A (en) * | 1982-03-05 | 1983-09-10 | 株式会社東芝 | X-ray diagnostic apparatus |
US4434820A (en) | 1982-05-05 | 1984-03-06 | Glass John P | Syringe loader and method |
US4823833A (en) | 1982-06-24 | 1989-04-25 | Baxter Healthcare Corporation | Fluid communication device |
US4515584A (en) * | 1982-07-06 | 1985-05-07 | Fujisawa Pharmaceutical Co., Ltd. | Artificial pancreas |
US4474476A (en) * | 1982-08-05 | 1984-10-02 | Jack Thomsen | Chemical printing liquid method and system |
US4512764A (en) | 1982-09-27 | 1985-04-23 | Wunsch Richard E | Manifold for controlling administration of multiple intravenous solutions and medications |
US4655197A (en) | 1982-12-01 | 1987-04-07 | Snyder Laboratories, Inc. | Lavage system with variable frequency, flow rate and pressure |
US4479761A (en) * | 1982-12-28 | 1984-10-30 | Baxter Travenol Laboratories, Inc. | Actuator apparatus for a prepackaged fluid processing module having pump and valve elements operable in response to externally applied pressures |
US4479762A (en) * | 1982-12-28 | 1984-10-30 | Baxter Travenol Laboratories, Inc. | Prepackaged fluid processing module having pump and valve elements operable in response to applied pressures |
US4479760A (en) * | 1982-12-28 | 1984-10-30 | Baxter Travenol Laboratories, Inc. | Actuator apparatus for a prepackaged fluid processing module having pump and valve elements operable in response to applied pressures |
US4585941A (en) | 1983-02-28 | 1986-04-29 | E. R. Squibb & Sons, Inc. | Dosimetry system for strontium-rubidium infusion pump |
US4625494A (en) | 1983-04-28 | 1986-12-02 | Pfrimmer & Co. Pharmazeutische Werke Erlangen | Method and apparatus for making mixtures of pharmaceutical liquids |
US4610670A (en) * | 1983-06-13 | 1986-09-09 | E. I. Du Pont De Nemours And Company | Sterile connection process, apparatus and system |
GB8318670D0 (en) * | 1983-07-11 | 1983-08-10 | Ici Plc | Fluid delivery apparatus |
US4798590A (en) * | 1983-11-22 | 1989-01-17 | Medical Technology Products, Inc. | Intravenous infusion pumping system including independent pump set |
JPS60114987A (en) * | 1983-11-25 | 1985-06-21 | 株式会社東芝 | Fare receiver |
US4559036A (en) * | 1983-12-14 | 1985-12-17 | Wunsch Richard E | Apparatus for controlling administration of multiple intravenous solutions and medications |
US4563175A (en) * | 1983-12-19 | 1986-01-07 | Lafond Margaret | Multiple syringe pump |
US4854324A (en) * | 1984-01-31 | 1989-08-08 | Medrad, Inc. | Processor-controlled angiographic injector device |
US5100380A (en) * | 1984-02-08 | 1992-03-31 | Abbott Laboratories | Remotely programmable infusion system |
US4610790A (en) * | 1984-02-10 | 1986-09-09 | Sterimatics Company Limited Partnership | Process and system for producing sterile water and sterile aqueous solutions |
FR2561949B1 (en) * | 1984-03-29 | 1991-05-03 | Arc Services | PARCEL TRANSPORTATION SYSTEM |
US4572724A (en) | 1984-04-12 | 1986-02-25 | Pall Corporation | Blood filter |
US4551133A (en) * | 1984-04-16 | 1985-11-05 | American Hospital Supply Corporation | Patient controlled medication infusion system |
JPH0614746B2 (en) * | 1984-09-13 | 1994-02-23 | 株式会社東芝 | X-ray image processing device |
US4634426A (en) * | 1984-12-11 | 1987-01-06 | Baxter Travenol Laboratories | Medical infusion controller and user interface |
US5088981A (en) | 1985-01-18 | 1992-02-18 | Howson David C | Safety enhanced device and method for effecting application of a therapeutic agent |
US4935005A (en) | 1985-06-05 | 1990-06-19 | Nestle, S.A. | Opthalmic fluid flow control system |
EP0231371B1 (en) * | 1985-08-06 | 1993-02-17 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Patient-controlled delivery of beneficial agents |
US4710166A (en) * | 1985-11-08 | 1987-12-01 | Quest Medical, Inc. | Automated drug additive infusion system |
JPH072182B2 (en) * | 1986-04-07 | 1995-01-18 | テルモ株式会社 | Infusion pump |
US4750643A (en) * | 1986-08-04 | 1988-06-14 | Sugrin Surgical Instrumentation, Inc. | Sterile fluid dispensing system and method |
US4754786A (en) * | 1986-09-05 | 1988-07-05 | Roderick Roberts | Sterile fluid storage and dispensing apparatus and method for filling same |
US4781687A (en) | 1986-10-16 | 1988-11-01 | Baxter Travenol Laboratories, Inc. | Irrigation system utilizing air bladder pressure regulator and method of use |
US4854301A (en) | 1986-11-13 | 1989-08-08 | Olympus Optical Co., Ltd. | Endoscope apparatus having a chair with a switch |
US4793357A (en) * | 1986-11-24 | 1988-12-27 | Picker International, Inc. | CT blood flow mapping with xenon gas enhancement |
US4936832A (en) | 1986-11-24 | 1990-06-26 | Vaillancourt Vincent L | Ambulatory disposable infusion delivery system |
US4789014A (en) | 1986-12-05 | 1988-12-06 | Baxter International Inc. | Automated system for adding multiple fluids to a single container |
US5056568A (en) | 1986-12-05 | 1991-10-15 | Clintec Nutrition Company | Automated system for adding multiple fluids to a single container |
JPS63164931A (en) | 1986-12-27 | 1988-07-08 | 株式会社東芝 | Constant pressure apparatus of endoscope |
SE457056B (en) * | 1987-01-29 | 1988-11-28 | Gambro Ab | SYSTEM FOR PREPARING A SCIENTIFIC INTENDED FOR MEDICAL TREATMENT |
JP2602823B2 (en) | 1987-03-11 | 1997-04-23 | 株式会社東芝 | Liquid feeding device for endoscope |
US4976687A (en) * | 1987-05-11 | 1990-12-11 | James Martin | Apparatus for controlling the supplying of intravenous fluids |
US4887554A (en) * | 1987-05-27 | 1989-12-19 | Whitford Darryl R | Animal drench |
US4877034A (en) * | 1987-06-18 | 1989-10-31 | Smith & Nephew, Inc. | Method and device for detection of tissue infiltration |
US4838856A (en) | 1987-07-02 | 1989-06-13 | Truckee Meadows Research & Development | Fluid infusion flow control system |
US4925444A (en) * | 1987-08-07 | 1990-05-15 | Baxter Travenol Laboratories, Inc. | Closed multi-fluid delivery system and method |
US5207642A (en) * | 1987-08-07 | 1993-05-04 | Baxter International Inc. | Closed multi-fluid delivery system and method |
DE3726452A1 (en) * | 1987-08-08 | 1989-02-16 | Schael Wilfried | Peristaltic pump for medical purposes |
US4880014A (en) * | 1987-08-14 | 1989-11-14 | Zarowitz Barbara J | Method for determining therapeutic drug dosage using bioelectrical resistance and reactance measurements |
US4795429A (en) | 1987-10-28 | 1989-01-03 | Feldstein Marvin A | Method and apparatus for use in the control of intravenous medication introduction |
US4835521A (en) * | 1987-11-05 | 1989-05-30 | Emhart Industries, Inc. | Fluid status detector |
US4874359A (en) | 1987-12-14 | 1989-10-17 | White Frederick R | Power infuser |
US4887208A (en) * | 1987-12-18 | 1989-12-12 | Schneider Bruce H | Sales and inventory control system |
US4853521A (en) * | 1987-12-28 | 1989-08-01 | Claeys Ronald W | System for verifying and recording drug administration to a patient |
US5053002A (en) | 1988-01-11 | 1991-10-01 | Olympus Corporation | Irrigation system for angioscope |
GB8808305D0 (en) | 1988-04-08 | 1988-05-11 | Nycomed As | Compositions |
DE3812584A1 (en) * | 1988-04-13 | 1989-10-26 | Mic Medical Instr Corp | DEVICE FOR BIOFEEDBACK CONTROL OF BODY FUNCTIONS |
US4901731A (en) * | 1988-04-27 | 1990-02-20 | Millar Instruments, Inc. | Single sensor pressure differential device |
DE3817411A1 (en) * | 1988-05-21 | 1989-11-30 | Fresenius Ag | MULTIPLE INFUSION SYSTEM |
US4857056A (en) * | 1988-07-06 | 1989-08-15 | Sherwood Medical Company | Auto-flush syringe pump |
US4950245A (en) * | 1988-07-08 | 1990-08-21 | I-Flow Corporation | Multiple fluid cartridge and pump |
US4954129A (en) | 1988-07-25 | 1990-09-04 | Abbott Laboratories | Hydrodynamic clot flushing |
US5021046A (en) | 1988-08-10 | 1991-06-04 | Utah Medical Products, Inc. | Medical pressure sensing and display system |
US4946439A (en) * | 1988-08-15 | 1990-08-07 | Critikon, Inc. | Dual source parenteral infusion system with secondary infusion module |
US4943279A (en) * | 1988-09-30 | 1990-07-24 | C. R. Bard, Inc. | Medical pump with infusion controlled by a detachable coded label |
US4929818A (en) * | 1988-11-15 | 1990-05-29 | Rainbarrel Corporation | Method and apparatus for vending a containerized product on multiple occasions following at least one refill of the container with the product |
US4946256A (en) * | 1989-01-11 | 1990-08-07 | Nm Laser Products, Inc. | Right angle shutter for laser beam |
US4879880A (en) * | 1989-01-17 | 1989-11-14 | Frank Harrison | Air temperature regulator |
US5153827A (en) * | 1989-01-30 | 1992-10-06 | Omni-Flow, Inc. | An infusion management and pumping system having an alarm handling system |
US5009654A (en) * | 1989-03-10 | 1991-04-23 | Baxter International Inc. | Sterile product and method for sterilizing and assembling such product |
US5113905A (en) * | 1989-03-27 | 1992-05-19 | Michael D. Hoyle | Carbon dioxide fill manifold and method |
US5084828A (en) | 1989-09-29 | 1992-01-28 | Healthtech Services Corp. | Interactive medication delivery system |
US5267174A (en) | 1989-09-29 | 1993-11-30 | Healthtech Services Corp. | Interactive medication delivery system |
US4978335A (en) * | 1989-09-29 | 1990-12-18 | Medex, Inc. | Infusion pump with bar code input to computer |
US5032112A (en) | 1989-11-22 | 1991-07-16 | Baxter International Inc. | Dual source intravenous administration set having an intravenous pump |
US5104374A (en) * | 1990-01-16 | 1992-04-14 | Bishko Jay R | Electronic fluid flow rate controller for controlling the infusion of intravenous drugs into a patient |
US4981467A (en) * | 1990-02-27 | 1991-01-01 | Baxter International Inc. | Apparatus and method for the detection of air in fluid delivery systems |
US5059173A (en) * | 1990-04-04 | 1991-10-22 | Sacco John J | IV apparatus |
US5191878A (en) * | 1990-04-12 | 1993-03-09 | Olympus Optical Co., Ltd. | Endoscope device |
US5199604A (en) * | 1990-05-04 | 1993-04-06 | Sultan Chemists, Inc. | Irrigation system and method for delivering a selected one of multiple liquid solutions to a treatment site |
US5078683A (en) * | 1990-05-04 | 1992-01-07 | Block Medical, Inc. | Programmable infusion system |
US5104387A (en) * | 1990-05-25 | 1992-04-14 | St. Jude Medical, Inc. | Bi-planar fluid control valve |
US5108365A (en) * | 1990-06-20 | 1992-04-28 | Woods Jr Walter T | Transluminal infusion of magnesium during coronary angioplasty |
CA2045070A1 (en) * | 1990-07-31 | 1992-02-01 | Kazuaki Mizoguchi | Control system for dsa and ptca |
MY106779A (en) * | 1990-09-07 | 1995-07-31 | Mitsubishi Heavy Ind Ltd | Magnetic recording method and circuit for toll road ticket. |
IL95743A (en) * | 1990-09-19 | 1993-02-21 | Univ Ramot | Method of measuring blood flow |
US5180896A (en) | 1990-10-11 | 1993-01-19 | University Of Florida | System and method for in-line heating of medical fluid |
US5133336A (en) * | 1990-10-22 | 1992-07-28 | Endoscopy Support Services, Inc. | Disposable liquid supply system for use in an endoscope |
JPH04160469A (en) * | 1990-10-23 | 1992-06-03 | Matsushita Electric Ind Co Ltd | Automatic order vending management system using facsimile |
GB2252656B (en) * | 1991-02-11 | 1994-12-14 | Keymed | Improvements in endoscopy training apparatus |
JPH04322633A (en) * | 1991-04-19 | 1992-11-12 | Olympus Optical Co Ltd | Endoscope |
DE4121568C2 (en) * | 1991-04-22 | 1997-07-03 | Schering Ag | Method and device for producing a contrast medium from a concentrate |
US5339799A (en) * | 1991-04-23 | 1994-08-23 | Olympus Optical Co., Ltd. | Medical system for reproducing a state of contact of the treatment section in the operation unit |
US5196007A (en) * | 1991-06-07 | 1993-03-23 | Alan Ellman | Electrosurgical handpiece with activator |
US5207645A (en) * | 1991-06-25 | 1993-05-04 | Medication Delivery Devices | Infusion pump, treatment fluid bag therefor, and method for the use thereof |
WO1993012828A1 (en) | 1991-12-20 | 1993-07-08 | Abbott Laboratories | Drug channel identification and security system for infusion and pumping systems |
WO1993012825A1 (en) | 1991-12-20 | 1993-07-08 | Abbott Laboratories | Automated drug infusion system with autopriming |
US5273537A (en) * | 1992-03-06 | 1993-12-28 | Scimed Life Systems, Inc. | Power-assisted inflation apparatus |
US5382232A (en) | 1992-03-13 | 1995-01-17 | Ivac Corporation | Infusion system with air-in-line clear function |
DE4210120C1 (en) * | 1992-03-27 | 1993-08-05 | Siemens Ag, 8000 Muenchen, De | X=ray appts. for peripheral angiography - calculates relative positioning of appts. and patient support using data derived from patient |
US5230614A (en) * | 1992-06-03 | 1993-07-27 | Allergan, Inc. | Reduced pulsation tapered ramp pump head |
US5361761A (en) * | 1992-06-17 | 1994-11-08 | Wisconsin Alumni Research Foundation | Method and apparatus for measuring blood iodine concentration |
US5352979A (en) * | 1992-08-07 | 1994-10-04 | Conturo Thomas E | Magnetic resonance imaging with contrast enhanced phase angle reconstruction |
US5310997A (en) * | 1992-09-10 | 1994-05-10 | Tandy Corporation | Automated order and delivery system |
US5328463A (en) * | 1992-09-18 | 1994-07-12 | Namic U.S.A. Corporation | Contrast media and fluid introduction system |
US5338662A (en) * | 1992-09-21 | 1994-08-16 | Bio-Preserve Medical Corporation | Organ perfusion device |
CA2125693C (en) * | 1992-10-15 | 2005-05-03 | Alan D. Ford | An infusion pump with an electronically loadable drug library |
US5349635A (en) | 1992-11-19 | 1994-09-20 | At&T Bell Laboratories | Half-duplex or full-duplex automode operation for use in data communications equipment |
US5378231A (en) | 1992-11-25 | 1995-01-03 | Abbott Laboratories | Automated drug infusion system |
GB9225014D0 (en) * | 1992-11-30 | 1993-01-20 | Univ Hospital London Dev Corp | Pulse injector for quantitative angiographic blood-flow measurements |
JPH06211323A (en) * | 1992-11-30 | 1994-08-02 | Olympus Optical Co Ltd | Physical distribution control system |
US5313992A (en) | 1992-12-11 | 1994-05-24 | Abbott Laboratories | Transfer tubing set for compounding solutions |
US5354273A (en) * | 1992-12-14 | 1994-10-11 | Mallinckrodt Medical, Inc. | Delivery apparatus with pressure controlled delivery |
WO1994015664A1 (en) * | 1993-01-07 | 1994-07-21 | Man Fai Shiu | Manifold |
US5474683A (en) | 1993-03-03 | 1995-12-12 | Deka Products Limited Partnership | Peritoneal dialysis systems and methods employing pneumatic pressure and temperature-corrected liquid volume measurements |
US5385540A (en) | 1993-05-26 | 1995-01-31 | Quest Medical, Inc. | Cardioplegia delivery system |
US5579767A (en) | 1993-06-07 | 1996-12-03 | Prince; Martin R. | Method for imaging abdominal aorta and aortic aneurysms |
US5417213A (en) | 1993-06-07 | 1995-05-23 | Prince; Martin R. | Magnetic resonance arteriography with dynamic intravenous contrast agents |
US5590654A (en) | 1993-06-07 | 1997-01-07 | Prince; Martin R. | Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
DE4320365C2 (en) | 1993-06-19 | 2000-07-13 | Uvo Hoelscher | Multi-channel dosing system |
FR2708166A1 (en) * | 1993-07-22 | 1995-01-27 | Philips Laboratoire Electroniq | A method of processing digitized images for the automatic detection of stenoses. |
US5368562A (en) | 1993-07-30 | 1994-11-29 | Pharmacia Deltec, Inc. | Systems and methods for operating ambulatory medical devices such as drug delivery devices |
US5515851A (en) | 1993-07-30 | 1996-05-14 | Goldstein; James A. | Angiographic fluid control system |
EP1258262A3 (en) * | 1993-10-28 | 2002-12-18 | Medrad, Inc. | Total system for contrast delivery |
EP0650738B1 (en) * | 1993-10-28 | 2003-05-02 | Medrad, Inc. | Multi-patient fluid dispensing |
US5569181A (en) * | 1993-10-28 | 1996-10-29 | Medrad, Inc. | Sterility assurance for contrast delivery system |
US5431627A (en) | 1993-11-12 | 1995-07-11 | Abbott Laboratories | Cassette identification system for use with a multi-program drug infusion pump |
US5460609A (en) | 1993-11-22 | 1995-10-24 | Advanced Cardiovascular Systems, Inc. | Electromechanical inflation/deflation system |
US5531697A (en) | 1994-04-15 | 1996-07-02 | Sims Deltec, Inc. | Systems and methods for cassette identification for drug pumps |
US5494036A (en) | 1993-11-26 | 1996-02-27 | Medrad, Inc. | Patient infusion system for use with MRI |
US5464391A (en) | 1994-03-03 | 1995-11-07 | Northgate Technologies Inc. | Irrigation system for a surgical site |
US5531679A (en) | 1994-03-14 | 1996-07-02 | Schulman; Joseph H. | Fluidic infusion system for catheter or probe |
US5489265A (en) | 1994-06-15 | 1996-02-06 | Ivac Corporation | Restrictor fitting for an infusion pump |
US5458128A (en) * | 1994-06-17 | 1995-10-17 | Polanyi; Michael | Method and apparatus for noninvasively measuring concentration of a dye in arterial blood |
US5522798A (en) | 1994-10-17 | 1996-06-04 | Abbott Laboratories | Control of a multi-channel drug infusion pump using a pharmacokinetic model |
US5560317A (en) * | 1994-10-19 | 1996-10-01 | N J Phillips Pty Limited | Mechanism to dispense medication to animals |
US5533978A (en) | 1994-11-07 | 1996-07-09 | Teirstein; Paul S. | Method and apparatus for uninterrupted delivery of radiographic dye |
WO1996032887A1 (en) | 1995-04-20 | 1996-10-24 | Invasatec, Inc. | Radiographic contrast material injector |
US6221045B1 (en) * | 1995-04-20 | 2001-04-24 | Acist Medical Systems, Inc. | Angiographic injector system with automatic high/low pressure switching |
US5882343A (en) | 1995-04-20 | 1999-03-16 | Invasatec, Inc. | Dual port syringe |
US6099502A (en) * | 1995-04-20 | 2000-08-08 | Acist Medical Systems, Inc. | Dual port syringe |
US5573515A (en) | 1995-04-20 | 1996-11-12 | Invasatec, Inc. | Self purging angiographic injector |
US5569208A (en) | 1995-08-01 | 1996-10-29 | Merit Medical Systems, Inc. | System for managing delivery of contrast media |
US5988587A (en) | 1997-10-10 | 1999-11-23 | Invasatec, Inc. | Control device for providing a variable control signal to a fluid-supplying machine |
US5916165A (en) | 1997-11-06 | 1999-06-29 | Invasatec, Inc. | Pneumatic controller and method |
-
1994
- 1994-09-21 US US08/309,820 patent/US5840026A/en not_active Expired - Lifetime
-
1995
- 1995-09-21 EP EP95202547A patent/EP0702966B1/en not_active Expired - Lifetime
- 1995-09-21 EP EP02020247A patent/EP1262206A3/en not_active Withdrawn
- 1995-09-21 DE DE69530035T patent/DE69530035T2/en not_active Expired - Lifetime
-
1998
- 1998-11-23 US US09/197,773 patent/US6385483B1/en not_active Expired - Lifetime
-
2000
- 2000-12-29 US US09/749,894 patent/US6889074B2/en not_active Expired - Fee Related
-
2002
- 2002-05-06 US US10/139,995 patent/US20030050556A1/en not_active Abandoned
-
2004
- 2004-02-11 US US10/775,235 patent/US7313431B2/en not_active Expired - Fee Related
-
2007
- 2007-05-23 US US11/752,451 patent/US20070225601A1/en not_active Abandoned
- 2007-05-23 US US11/752,478 patent/US20070282199A1/en not_active Abandoned
- 2007-08-21 US US11/842,325 patent/US20080045834A1/en not_active Abandoned
Patent Citations (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3523523A (en) * | 1966-06-30 | 1970-08-11 | Contraves Ag | Power driven medical injector syringe with electromagnetic coupling means |
US3520295A (en) * | 1968-03-06 | 1970-07-14 | Gen Electric | Cardiac r-wave detector with automatic gain control |
US4151845A (en) * | 1977-11-25 | 1979-05-01 | Miles Laboratories, Inc. | Blood glucose control apparatus |
US4263916A (en) * | 1978-03-27 | 1981-04-28 | University Of Southern California | Image averaging for angiography by registration and combination of serial images |
US4448200A (en) * | 1978-03-27 | 1984-05-15 | University Of Southern California | System and method for dynamic background subtraction |
US4392847A (en) * | 1979-01-08 | 1983-07-12 | Whitney Douglass G | Injection and monitoring system |
US4280494A (en) * | 1979-06-26 | 1981-07-28 | Cosgrove Robert J Jun | System for automatic feedback-controlled administration of drugs |
US4392849A (en) * | 1981-07-27 | 1983-07-12 | The Cleveland Clinic Foundation | Infusion pump controller |
US4477923A (en) * | 1982-02-03 | 1984-10-16 | Siemens Aktiengesellschaft | X-ray diagnostic system for angiographic radiographs |
US4504908A (en) * | 1982-03-15 | 1985-03-12 | General Electric Company | Matched filter for X-ray temporal subtraction |
US4542459A (en) * | 1982-11-26 | 1985-09-17 | General Electric Company | Matched filter for x-ray hybrid subtraction |
US4612572A (en) * | 1983-03-31 | 1986-09-16 | Tokyo Shibaura Denki Kabushiki Kaisha | X-ray television diagnostic apparatus |
US4611340A (en) * | 1983-05-20 | 1986-09-09 | Kabushiki Kaisha Toshiba | Apparatus for examining a biological object by using radiation |
US4578802A (en) * | 1983-06-27 | 1986-03-25 | Kabushiki Kaisha Toshiba | X-ray diagnostic apparatus for allowing stereoscopic visualization on X-ray images of an object under examination |
US4723261A (en) * | 1983-12-22 | 1988-02-02 | U.S. Philips Corporation | X-ray examination apparatus incorporating image subtraction |
US4689670A (en) * | 1984-01-19 | 1987-08-25 | Kabushiki Kaisha Toshiba | Method and apparatus for measuring a biological function of a subject |
US4903705A (en) * | 1984-11-09 | 1990-02-27 | Hitachi Medical Corporation | Digital radiography apparatus |
US4676776A (en) * | 1985-01-18 | 1987-06-30 | Intelligent Medicine, Inc. | Device and method for effecting application of a therapeutic agent |
US4672651A (en) * | 1985-03-28 | 1987-06-09 | Hitachi Medical Corporation | Method of and apparatus for reconstructing shape of interested part of object through irradiation with X-rays |
US4804454A (en) * | 1986-03-19 | 1989-02-14 | Honda Giken Kagyo Kabushiki Kaisha | Oxygen concentration sensing apparatus |
US5054044A (en) * | 1986-05-06 | 1991-10-01 | Thomson-Cgr | Radiology installation with a communications network |
US4943987A (en) * | 1987-08-07 | 1990-07-24 | Kabushiki Kaisha Toshiba | Method and system for displaying X-ray images of blood-vessel structure parts of subject |
US4913154A (en) * | 1987-11-19 | 1990-04-03 | Siemens Aktiengesellschaft | Medical examination installation with improved image contrast |
US5286252A (en) * | 1988-02-19 | 1994-02-15 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
US5018173A (en) * | 1988-10-18 | 1991-05-21 | Kabushiki Kaisha Toshiba | Diagnosis apparatus using X-ray CT device |
US5228070A (en) * | 1988-10-20 | 1993-07-13 | Picker International, Inc. | Constant image quality CT scanner with variable radiation flux density |
US4947412A (en) * | 1988-10-20 | 1990-08-07 | Picker International, Inc. | X-ray detector for CT scanners |
US5262946A (en) * | 1988-10-20 | 1993-11-16 | Picker International, Inc. | Dynamic volume scanning for CT scanners |
US4965726A (en) * | 1988-10-20 | 1990-10-23 | Picker International, Inc. | CT scanner with segmented detector array |
US5166961A (en) * | 1988-10-20 | 1992-11-24 | Picker International, Inc. | CT scanner having multiple detector widths |
US5034987A (en) * | 1988-12-09 | 1991-07-23 | Nippon Identograph Co., Ltd. | Continuous photographing and observing of a three-dimensional image |
US5010473A (en) * | 1989-08-31 | 1991-04-23 | Duke University | Method and apparatus for model-based control of an open-loop process |
US5150292A (en) * | 1989-10-27 | 1992-09-22 | Arch Development Corporation | Method and system for determination of instantaneous and average blood flow rates from digital angiograms |
US5276614A (en) * | 1989-11-17 | 1994-01-04 | Picker International, Inc. | Dynamic bandwidth reconstruction |
US5388139A (en) * | 1989-12-07 | 1995-02-07 | Electromed International | High-voltage power supply and regulator circuit for an X-ray tube with closed-loop feedback for controlling X-ray exposure |
US4995064A (en) * | 1990-01-29 | 1991-02-19 | Siemens Medical Systems, Inc. | Continuously sweeping multiple-pass image acquisition system for peripheral angiography |
US5123056A (en) * | 1990-02-02 | 1992-06-16 | Siemens Medical Systems, Inc. | Whole-leg x-ray image processing and display techniques |
US5249579A (en) * | 1990-03-09 | 1993-10-05 | E-Z-Em, Inc. | Contrast media injector |
US5190744A (en) * | 1990-03-09 | 1993-03-02 | Salutar | Methods for detecting blood perfusion variations by magnetic resonance imaging |
US5249122A (en) * | 1990-03-15 | 1993-09-28 | Mount Sinai School Of Medicine Of The City University Of New York | Method and apparatus for forming images using orthogonal polynomials for temporal deconvolution |
US5287273A (en) * | 1990-03-15 | 1994-02-15 | Mount Sinai School Of Medicine | Functional organ images |
US5125018A (en) * | 1990-06-29 | 1992-06-23 | Kabushiki Kaisha Toshiba | X-ray diagnostic apparatus |
US5111492A (en) * | 1990-07-06 | 1992-05-05 | General Electric Cgr S.A. | X-ray diagnosis system for angiographic examination with device for the automatic tracking of a contrast medium |
US5215095A (en) * | 1990-08-10 | 1993-06-01 | University Technologies International | Optical imaging system for neurosurgery |
US5450847A (en) * | 1991-04-22 | 1995-09-19 | Schering Aktiengesellschaft | Process for making doses formulation of contrast media from concentrate |
US5301672A (en) * | 1991-12-09 | 1994-04-12 | Siemens Aktiengesellschaft | Radiological diagnostics system employing a contrast agent |
US5311568A (en) * | 1992-05-01 | 1994-05-10 | Picker International, Inc. | Optical alignment means utilizing inverse projection of a test pattern/target |
US5840026A (en) * | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9289550B1 (en) | 2001-02-06 | 2016-03-22 | Bayer Healthcare Llc | Apparatus and method for detecting fluid extravasation |
US10166326B2 (en) | 2004-11-24 | 2019-01-01 | Bayer Healthcare Llc | Devices, systems and methods for determining parameters of one or more phases of an injection procedure |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
US9959389B2 (en) | 2010-06-24 | 2018-05-01 | Bayer Healthcare Llc | Modeling of pharmaceutical propagation and parameter generation for injection protocols |
US11234608B2 (en) | 2011-09-02 | 2022-02-01 | Battelle Memorial Institute | Extravasation and infiltration detection device with fluid guide provided on a substrate of the detection device to adjust fluid rate based on detection signal |
US10722136B2 (en) | 2011-09-02 | 2020-07-28 | Battelle Memorial Institute | Wireless and power-source-free extravasation and infiltration detection sensor |
US10987017B2 (en) | 2011-09-02 | 2021-04-27 | Battelle Memorial Institute | Distributed extravasation detecton system |
US11883143B2 (en) | 2011-09-02 | 2024-01-30 | Battelle Memorial Institute | Wireless and power-source-free extravasation and infiltration detection sensor circuitry provided on a substrate with signal splitter |
US11883144B2 (en) | 2011-09-02 | 2024-01-30 | Battelle Memorial Institute | Integrated extravasation and infiltration detection device on a RF isolated flexible substrate with fluid guide to detect fluid changes via signal comparison |
US11986281B2 (en) | 2011-09-02 | 2024-05-21 | Battelle Memorial Institute | Distributed extravasation detection system for fluid change and to control the fluids levels in a body via wireless interface based on rate of activation |
US9760830B2 (en) | 2011-12-28 | 2017-09-12 | Siemens Aktiengesellschaft | Control method and control system |
US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US11191501B2 (en) | 2012-05-14 | 2021-12-07 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
Also Published As
Publication number | Publication date |
---|---|
EP1262206A2 (en) | 2002-12-04 |
US6889074B2 (en) | 2005-05-03 |
US20030050556A1 (en) | 2003-03-13 |
US6385483B1 (en) | 2002-05-07 |
US20080045834A1 (en) | 2008-02-21 |
EP0702966A2 (en) | 1996-03-27 |
EP0702966B1 (en) | 2003-03-26 |
US5840026A (en) | 1998-11-24 |
EP1262206A3 (en) | 2003-03-19 |
US20010056233A1 (en) | 2001-12-27 |
US7313431B2 (en) | 2007-12-25 |
DE69530035T2 (en) | 2003-09-25 |
US20040162488A1 (en) | 2004-08-19 |
EP0702966A3 (en) | 1996-08-07 |
US20070225601A1 (en) | 2007-09-27 |
DE69530035D1 (en) | 2003-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6385483B1 (en) | Patient specific dosing contrast delivery systems and methods | |
JP6208205B2 (en) | System for generating patient-based parameters for medical infusion procedures | |
US11191501B2 (en) | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage | |
EP0869738B1 (en) | Predicting ct contrast enhancement with feedback | |
US5014715A (en) | Device for measuring the impedance to flow of a natural or prosthetic vessel in a living body | |
JP7343399B2 (en) | Systems and methods for generation of split bolus protocols | |
CN108992743B (en) | Injection method and device for automatically generating injection plan | |
RU2722547C2 (en) | Systems and methods for determining protocols for injecting a pharmaceutical liquid based on voltage on an x-ray tube |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDRAD, INC., PENNSYLVANIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:UBER, ARTHUR E., III;HIRSCHMAN, ALAN D.;WELCH, THOMAS R.;AND OTHERS;REEL/FRAME:019333/0751;SIGNING DATES FROM 19940915 TO 19940919 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |